Page last updated: 2024-08-24

adenosine and Innate Inflammatory Response

adenosine has been researched along with Innate Inflammatory Response in 363 studies

Research

Studies (363)

Timeframe	Studies, this research(%)	All Research%
pre-1990	11 (3.03)	18.7374
1990's	16 (4.41)	18.2507
2000's	105 (28.93)	29.6817
2010's	153 (42.15)	24.3611
2020's	78 (21.49)	2.80

Authors

Authors	Studies
Edwards, BS; Graves, SW; Saunders, MJ; Sklar, LA; Zhu, J	1
Chen, J; Dai, Y; Ding, X; Fang, Y; Hu, J; Liang, Y; Liu, H; Lu, Z; Ning, Y; Song, N; Teng, J; Zhu, J; Zou, J	1
Bauche, A; Behrends, J; Brenna, S; Cortesi, F; Fliegert, R; Gagliani, N; Lauten, M; Magnus, T; Meyer-Schwesinger, C; Müller, CE; Puig, B; Reimer, R; Ricklefs, FL; Ricklefs, I; Rissiek, A; Rissiek, B; Schneider, E; Tolosa, E; Wasielewski, H; Winzer, R	1
Antonioli, L; Haskó, G; Pacher, P	1
Bai, H; Gao, L; Jiao, G; Li, T; Liu, L; Ma, T; Song, X; Wang, X; Zhang, Z	1
Chen, J; Han, X; He, J; Jiang, G; Liu, G; Xiao, Q; Xu, H; Yang, Q; Yao, Z; Zhang, L; Zhou, D; Zhou, J; Zhou, P	1
Biros, E; Dlaska, C; Dobson, GP; Hazratwala, K; Letson, HL; McEwen, P; Morris, JL; Wilkinson, M	1
Fu, J; Gao, Y; Han, X; Huang, S; Li, W; Liang, Q; Xia, L; Xiao, W; Yang, L; Yu, H; Zhang, C; Zhou, Y; Zhu, R	1
Bellezza, I; Cellini, B; Fallarino, F; Gargaro, M; Llorente, A; Manni, G; Mezzasoma, L; Orvietani, P; Pascucci, L; Romani, R; Sagini, K; Scarpelli, P; Talesa, VN	1
Andreadou, M; Arapatzi, C; Chatzimike, M; Dushku, E; Gargani, S; Hatzis, P; Kontoyiannis, DL; Kostourou, V; Lourou, N; Ntafis, V; Saridaki, M; Sidiropoulos, ND; Tzanos, D	1
Chen, LH; Huang, L; Li, YZ; Xu, HQ; Yang, C; Zhang, C; Zhao, YY	1
Cai, J; Cai, M; Li, A; Li, J; Lv, Y; Ma, Q; Wu, W; Zhao, W	1
Chen, J; Chen, S; Chen, X; Chen, Y; Guo, A; Hu, C; Li, T; Lin, C; Xu, H; Yang, J; Zhu, Y	1
Ahmed, S; Carsons, SE; De Leon, J; Kasselman, L; Reiss, AB; Teboul, I	1
Hao, WY; Hu, GY; Liang, WR; Lou, Y; Qian, CY; Wang, XH; Zhao, J	1
Lan, J; Pan, Q; Shi, X; Tao, Q; Xu, B	1
Hasbak, P; Kjaer, A; Knudsen, A; Lebech, AM; Sølund, C; Weis, N	1
Prince, A; Urso, A	1
Booshehri, LM; Broderick, L; Feldstein, AE; Friess, H; Hartmann, D; Hoffman, HM; Kaufmann, B; Kim, AD; Kui, L; Leszczynska, A; Reca, A; Wree, A	1
Kawano, M; Matsushita, S; Takagi, R; Tokano, M	1
Ahmad, S; Blancke, G; Botzki, A; de Reuver, R; Declercq, W; Dierick, E; Hessmann, E; Hur, S; Jans, M; Maelfait, J; Nemegeer, J; van Loo, G; Van Nieuwerburgh, F; Vandenabeele, P; Verdonck, S; Vereecke, L	1
Bali, V; Eltzschig, HK; Fried, DE; Grubišić, V; Gulbransen, BD; Mazei-Robison, MS; Robson, SC	1
Abdelbaset-Ismail, A; Adamiak, M; Brzezniakiewicz-Janus, K; Chumak, V; Kucia, M; Ratajczak, J; Ratajczak, MZ; Thapa, A	1
Aguet, F; Fan, B; Geisinger, JM; Gloudemans, MJ; Li, JB; Li, Q; Li, YI; Ma, JB; Montgomery, SB; Pritchard, JK; Ramaswami, G; Sun, T	1
Cao, Z; Dong, X; Fu, J; Tu, Q; Wu, F; Xie, H; Xu, H	1
Ma, T; Yu-Jing, L; Zhang, T	1
Huang, J; Jin, H; Wang, Y	1
Hu, Z; Huang, C; Liu, J; Sun, G; Wan, L; Wang, K; Zhu, L; Zhu, Z	1
Catarinicchia, S; Jacobson, KA; Lucarini, L; Marri, S; Masini, E; Pini, A; Salvemini, D; Sgambellone, S; Tosh, DK	1
Ganama, M; Hua, X; Tilley, S; Varga, SM; Waldstein, KA	1
Arthur, JM; Arulprakash, N; Corken, A; Dai, J; Davis, O; Hedayati, SS; Jain, N; Mehta, JL; Phadnis, MA; Rahmatallah, Y; Smyth, S; Ware, J	1
Effendi, WI; Nagano, T	1
Magnus, T; Rissiek, B; Schädlich, IS; Stabernack, J; Tolosa, E; Winzer, R	1
Jacobson, KA; Pradhan, B; Pramanik, A; Wen, Z	1
Ding, J; Hu, T; Jiang, M; Li, F; Li, Q; Li, Z; Wang, J; Wu, C; Xu, L; Zhang, F	1
Cao, X; Gu, Z; Peng, X; Tang, Y; Wan, J; Wang, X; Yu, X; Zhou, X; Zhu, K	1
Bai, Z; Jia, S; Li, Y; Liu, Y; Ma, H; Wang, H; Wang, J; Wang, T; Yan, R; Yang, L; Zhang, G; Zhang, X; Zhao, Y	1
Cutler, CW; Dawson, S; Huo, Y; Messer, R; Morandini, AC; Paladines, N; Ramos-Junior, ES; Ryan, W; Serrano-Lopez, R	1
Barbas, C; Cuezva, JM; Del-Arco, A; Domínguez-Zorita, S; Esparza-Moltó, PB; Núñez de Arenas, C; Romero-Carramiñana, I; Saiz, J; Santacatterina, F; Simó, C	1
Geng, Z; Han, C; Huang, H; Li, W; Li, Z; Liu, R; Pan, X; Wang, Y; Zhang, Y; Zhao, Z; Zuo, X	1
Du, G; Huang, N; Jiang, J; Kang, J; Ning, B; Sun, Z; Yang, S; Zhang, X; Zhang, Y	1
Chen, ZH; Du, J; Jia, LX; Liu, TT; Piao, CM; Shen, HH; Wang, YL; Zhang, J; Zhang, Z; Zheng, S	1
de Sánchez, VC; de Vaca, RP; Domínguez-López, M; Guerrero-Celis, N; Rodríguez-Aguilera, JR; Velasco-Loyden, G	1
Luan, Z; Wang, Y	1
Becker, K; Bouvain, P; Flögel, U; Grandoch, M; Ibrahim, F; Massold, T; Niemann, V; Schrader, J; Steckel, B; Stegbauer, J; Temme, S	1
Abdan, Z; Allahyari, H; Amini, K; Assar, S; Dastbaz, M; Kafi, H; Lotfi, R; Roghani, SA; Rostampour, R; Shahrokhvand, SZ; Taghadosi, M	1
Haag, F; Magnus, T; Mittrücker, HW; Puig, B; Rissiek, A; Rissiek, B; Schneider, E; Tolosa, E; Winzer, R	1
Bedoui, Y; Gasque, P; Giry, C; Guillot, X; Guiraud, P; Jaffar-Bandjee, MC; Ralandison, S; Sélambarom, J	1
An, XM; Leung, WK; Lv, MM; Ren, TH; Seto, WK	1
Feng, M; He, C; Hou, J; Hu, B; Huang, X; Liu, J; Lu, Z; Shen, B; Smyth, MJ; Sun, B; Wang, J; Xia, Q; Zhang, H; Zhao, Z; Zhou, J	1
Chern, Y; Chou, FY; Lee, CY; Lin, CJ; Wu, KC	1
Dai, C; Ding, H; Jia, C; Su, Y; Zhang, X	1
Coutinho-Silva, R; Di Virgilio, F; Sarti, AC	1
Onuora, S	1
da Silva, RP; Eudy, BJ; Fernandez, G; Lai, J; Mathews, CE; McDermott, CE	1
Cadassou, O; Cros-Perrial, E; Jordheim, LP; Strakhova, R	1
Amblard, F; Bassit, L; Costa, VV; Cox, BD; Del Sarto, JL; Gavegnano, C; Guimarães, MZ; Olmo, IG; Pedrosa, CDSG; Queiroz-Junior, CM; Rehen, S; Ribeiro, FM; Rocha, RPF; Schinazi, RF; Teixeira, MM; Valiate, B; Zhou, L	1
Dwyer, KM; Kishore, BK; Robson, SC	1
Buccioni, M; Coelho, JE; Dal Ben, D; Lambertucci, C; Lopes, LV; Marques-Morgado, I; Martí Navia, A; Marucci, G; Spinaci, A; Volpini, R	1
Antonioli, L; Benvenuti, L; Blandizzi, C; D'Antongiovanni, V; Fornai, M; Pellegrini, C	1
Chen, K; Chen, X; Gao, C; Jia, Z; Jian, D; Jian, L; Li, M; Liu, Y; Rao, L; Shen, X; Tang, H; Wang, S; Wang, Y; Zhang, W	1
Han, DX; Wang, CB; Wang, XL; Zhao, J	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Aune, TM; Crooke, PS; Farley, VM; Heinrich, RM; Tossberg, JT	1
Campos, J; Choe, J; Durko, J; Gregory, RI; Ivanova, I; Kranc, KR; Krause, DS; Lawson, H; Mapperley, C; Mead, AJ; Morgan, M; Much, C; O'Carroll, D; Paris, J; Sarapuu, A; Tavosanis, A; van de Lagemaat, LN; von Kriegsheim, A; Wotherspoon, D	1
Assumpção, JAF; Caumo, W; Cioato, SG; de Souza, A; Lopes, BC; Medeiros, HR; Medeiros, LF; Roesler, R; Torres, ILS	1
Su, Z; Wang, C; Xia, L; Yin, Q	1
Chen, D; Li, H; Li, J; Lu, T; Luo, X; Ma, R; Sun, W; Wen, W; Xu, R	1
Berg, NK; Eltzschig, HK; Li, X; Mills, T; Yuan, X; Zhang, K	1
da Silva, RP; Eudy, BJ	1
Griñán-Ferré, C; Izquierdo, V; Pallàs, M; Palomera-Ávalos, V	1
Battastini, AMO; Boeno, FP; de Fraga Dias, A; Figueiró, F; Moritz, CEJ; Munhoz, SV; Pizzato, PR; Reischak-Oliveira, A; Scholl, JN; Vieira, AF	1
Banks, MI; Grady, SM; Jaeckel, ER; Krause, BM; Murphy, CA; Sanders, RD; Sultan, ZW	1
Huang, L; Peng, J; Zhang, H; Zhang, JH; Zhang, T	1
Eubler, K; Heikelä, H; Köhn, FM; Kunz, L; Mayerhofer, A; Missel, A; Mundt, N; Pickl, U; Popper, B; Poutanen, M; Spehr, M; Strauss, L; Trottmann, M; Walenta, L	1
Czopik, A; Eltzschig, HK; Evans, SE; Yuan, X	1
Carlisle, C; Komarnytsky, S; Le Brun-Blashka, S; Metzger, B; Panda, C; Rathinasabapathy, T; Troup, JP; Varadharaj, S; Wagner, C	1
Haddad, M	1
Borea, PA; Contri, C; Pasquini, S; Varani, K; Vincenzi, F	1
Coumbe Gitter, MM; Fahl, WE; Goesch, TR; Verhoven, BM; Wilson, NA; Zeng, W; Zhong, W	1
Avan, A; Bahreyni, A; Behnam-Rassouli, R; Hassanian, SM; Khazaei, M; Parizadeh, MR; Rahmani, F; Ryzhikov, M; Samani, SS	1
Alter, C; Borg, N; Ding, Z; Quast, C; Schrader, J	1
Blankman, P; Hasan, D; Nieman, GF	1
Bald, T; Glodde, N; Hölzel, M; Kolanus, W; Landsberg, J; Long, GV; Lopez-Ramos, D; Madore, J; Nettersheim, D; Ngiow, SF; Quast, T; Ramis, BB; Reinhardt, J; Ribas, A; Schadendorf, D; Schmid-Burgk, JL; Schorle, H; Scolyer, RA; Smyth, MJ; Tumeh, PC; Tüting, T; Young, A	1
Avan, A; Bahreyni, A; Hassanian, SM; Khazaei, M; Ryzhikov, M; Samani, SS	1
Araújo, HL; Bottari, NB; Da Silva, AS; Fávero, JF; Jordão, RS; Lilenbaum, W; Machado, G; Morsch, VM; Perin, G; Schetinger, MRC; Severo, DRT; Silva, AD; Stefani, LM	1
Davenport, L; Dobson, GP; Letson, HL	1
de Mast, Q; El Messaoudi, S; Gerretsen, J; Gomes, M; Kiers, D; Kox, M; Pickkers, P; Riksen, NP; Rongen, GA; van der Heijden, WA; van der Ven, AJ; van Ede, L	1
Adam, R; Carbonell, T; Castro Benítez, C; Folch-Puy, E; García-Gil, A; Lopez, A; Panisello-Roselló, A; Roselló-Catafau, J; Zaouali, MA	1
Ceruti, S; Magni, G; Riccio, D	1
Battista, KD; Burney, KM; Colgan, SP; Dobrinskikh, E; Kao, DJ; Kitzenberg, D; Kominsky, DJ; Saeedi, BJ; Vázquez-Torres, A	1
Bowser, JL; Eltzschig, HK; Lee, JW; Yuan, X	1
Gurbel, PA; Jeong, YH; Tantry, US	1
Aires, ID; Ambrósio, AF; Baqi, Y; Boia, R; Cunha, RA; Elvas, F; Madeira, MH; Müller, CE; Rodrigues-Neves, AC; Santiago, AR; Szabó, EC; Tomé, ÂR; Tralhão, P	1
An, X; Bagi, Z; Boison, D; Dong, Z; Fulton, DJ; Hong, M; Huo, Y; Jiang, X; Li, Q; Liu, Z; Toque, HA; Wang, Y; Weintraub, NL; Wu, C; Xu, Y; Yan, S; Yang, Q; Zeng, X; Zhou, Y	1
Alam, MS; Cavanaugh, C; Costales, MG; Williams, KM	1
Hsieh, CL; Huang, CP; Liao, HY; Lin, YW	1
Dobson, G; Letson, H	1
Caiazzo, E; Carnuccio, R; Cicala, C; Ialenti, A; Morello, S	1
Chaloin, L; Fontanel, S; Jordheim, LP; Lionne, C; Peyrottes, S; Rahimova, R	1
Baldissera, MD; Baldisserotto, B; Souza, CF	1
Burton, M; Colas, RA; Curtis, AM; Dalli, J; Marques, RM; Souza, PR; Walker, ME; Zasłona, Z	1
Feng, Z; Li, Q; Meng, R; Xu, Q; Yi, B	1
Benko, M; Bismuth, G; Blüml, S; Burkard, TR; Cavaco-Paulo, A; Charvet, C; Feuillet, V; Fischer, MB; Huppa, JB; Lager, F; Le Roux, D; Leksa, V; Machacek, C; Matsuyama, T; Mitulovic, G; Ohradanova-Repic, A; Platzer, R; Renault, G; Stockinger, H; Suchanek, M; Zlabinger, GJ	1
Bai, J; Chen, W; Shi, B; Xiao, L; Yang, M; Zeng, W; Zhu, C	1
Chen, X; Gong, X; Jiang, R; Kuang, G; Li, K; Tie, H; Wan, J; Wang, B; Xie, T; Zhou, Q	1
Kim, MI; Kwon, HK; Lee, HJ; Park, HJ; Park, TS; Song, MJ	1
Du, H; Lu, Z; Wang, F; Wang, H; Wang, Y; Zhao, J; Zong, X	1
Jalkanen, S; Kaarniranta, K; Kauppinen, A; Korhonen, AM; Lehti, K; Losenkova, K; Loukovaara, S; Müller, CE; Yegutkin, GG; Zeiner, J; Zuccarini, M	1
Bartoszewski, R; Bulinska, A; Chlopicki, S; Jablonska, P; Jasztal, A; Koszalka, P; Kutryb-Zajac, B; Mierzejewska, P; Milczarek, R; Serocki, M; Slominska, EM; Smolenski, RT; Sucajtys-Szulc, E; Zabielska, MA	1
Joolharzadeh, P; St Hilaire, C	1
Chen, J; Duan, S; Gao, Z; Ge, Q; Guo, F; Guo, Z; Hu, Y; Lou, H; Mai, W; Meng, F; Zhang, B; Zhang, Z	1
Faas, MM; Plösch, T; Silva, L; Sobrevia, L; Toledo, F	1
Hashimoto, S; Hibi, T; Inomata, Y; Komohara, Y; Li, XK; Narita, Y; Que, W; Sakamoto, S; Sakisaka, M; Shimata, K; Uto, K; Yoshii, D; Zhong, L	1
Lian, ZQ; Peng, XY; Wang, MJ; Zhu, HB	1
Cai, L; Feng, Z; Li, Q; Xu, Q; Yu, R	1
Ge, J; Huang, Y; Kong, X; Zuo, Y	1
Abdalla, FH; Bernardes, VM; Braun, JBS; Casali, EA; Castilhos, LG; da Cruz, IBM; de Andrade, CM; de Oliveira, JS; Leal, DBR; Manzoni, AG; Passos, DF; Ruchel, JB	1
Li, J; Peng, X; Qu, K; Wang, M; Zhu, H	1
Almasri, IM; Kaur, A; Naik, RR; Shakya, AK	1
Lee, PY	1
Ailawadi, G; Barbery, C; Bhamidipati, CM; Kron, IL; Laubach, VE; Meher, AK; Mehta, GS; Moehle, CW; Owens, GK; Sharma, AK; Su, G; Upchurch, GR; Vigneshwar, NG	1
Camici, PG; Kaski, JC; Recio-Mayoral, A; Rimoldi, OE	1
Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Remessy, AB; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Han, G; Haroldo, TF; Liou, GI; Mohammad, S; Naime, M; White, R	1
Herrero, JF; Ramos-Zepeda, G	1
Giembycz, MA; Greer, S; Joshi, T; Newton, R; Page, CW; Yan, D	1
Darè, E; Fredholm, BB; Haugen, F; Lövdahl, C; Schulte, G; Valen, G; Yang, J; Zheng, X	1
Górska, A; Gołembiowska, K; Noworyta-Sokołowska, K	1
Bai, P; Csóka, B; Haskó, G; Kókai, E; Koscsó, B; Németh, ZH; Pacher, P; Töro, G; Virág, L	1
Whiteside, TL	1
Antonioli, L; Blandizzi, C; Haskó, G; Pacher, P	1
Gonzales, JN; Gorshkov, B; Lucas, R; Sridhar, S; Varn, MN; Verin, AD; Zemskov, EA; Zemskova, MA	1
Dinarvand, P; Hassanian, SM; Rezaie, AR	1
Asamitsu, K; Hamano, T; Ito, M; Komatsu, T; Okamoto, T; Yamakawa, T	1
Antonioli, L; Blandizzi, C; Colucci, R; Csóka, B; Fornai, M; Haskó, G; Kókai, E	1
Allain, G; Billault, C; Couturier, P; Delpech, PO; Giraud, S; Hauet, T; Marchand, E; Parkkinen, J; Saintyves, T; Thuillier, R; Vaahtera, L	1
Feng, X; He, Y; Qiu, Y; Ren, T; Tian, T; Wang, Z; Wu, W; Ye, S; Yu, C; Zhou, Y	1
Arasa, J; Martos, P; Montesinos, MC; Terencio, MC; Valcuende-Cavero, F	1
Bjerring, PN; Dale, N; Larsen, FS	1
Brown, KM; Ham, A; Kim, KY; Kim, M; Lee, HT	1
Borea, PA; Gessi, S; Merighi, S	1
Bitsche, M; Blumer, MJ; Brandacher, G; Grahammer, J; Hautz, T; Hermann, M; Hickethier, T; Kimelman, M; Krapf, C; Lee, WP; Margreiter, R; Messner, F; Pechriggl, EJ; Pratschke, J; Schneeberger, S; Zelger, B	1
Batisti, AP; Brito, RN; Madeira, F; Martins, DF; Mazzardo-Martins, L; Piovezan, AP; Santos, AR; Stramosk, J; Turnes, BL	1
Diebold, Y; Gasull, X; Guzman-Aranguez, A; Pintor, J	1
Lee, CY	1
Herrero, JF; Herrero-Zorita, C; Ramos-Zepeda, GA	1
Bynoe, MS; Mahamed, DA; Toussaint, LE	1
Ahmad, S; Bhatia, K; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI	1
Bai, Y; Guo, C; Liu, C; Shang, Q; Wang, Q; Zhang, L; Zhu, F	1
Andrews, K; Brown, M; Cardozo, M; Chen, Y; Cushing, TD; Duquette, J; Fisher, B; Gonzalez-Lopez de Turiso, F; Hao, X; He, X; Henne, KR; Hu, YL; Hungate, R; Johnson, MG; Kelly, RC; Lucas, B; McCarter, JD; McGee, LR; Medina, JC; Metz, DP; Mohn, D; Pattaropong, V; Pettus, LH; Reichelt, A; Rzasa, RM; San Miguel, T; Seganish, J; Shin, Y; Tasker, AS; Wahl, RC; Wannberg, S; Whittington, DA; Whoriskey, J; Yu, G; Zalameda, L; Zhang, D	1
de Groot, PG; de Mast, Q; Dinarello, CA; Fijnheer, R; Gasem, MH; Gomes, ME; Joosten, LA; Netea, MG; Riksen, N; Rongen, G; Tacke, S; Tunjungputri, RN; van de Veerdonk, FL; van den Berg, TN; van der Ven, AJ	1
Cataño-Cañizalez, YG; Cortés-Garcia, JD; Cortez-Espinosa, N; Guzman-Flores, JM; Portales-Perez, DP; Rodríguez-Rivera, JG; Vargas-Morales, JM	1
Ahmad, S; El-Remessy, A; El-Sherbini, A; Fulzele, S; Liou, GI; Matragoon, S; Radhakrishnan, R; Sangani, R	1
Fasching, A; Friederich-Persson, M; Hansell, P; Inagi, R; Palm, F; Persson, P	1
Alam, MS; Cavanaugh, C; Costales, MG; Williams, K	1
Bahar, B; Crean, D; Cummins, EP; McMorrow, JP; Mohan, H; Murphy, EP	1
Brandhorst, D; Brandhorst, H; Guenther, B; Johnson, PR; Theisinger, B	1
Eichin, D; Jalkanen, S; Laurila, JP; Salmi, M	1
Ajjan, RA; Dockrell, DH; Ecob, R; Faulkner, RE; Judge, HM; Khan, H; Outteridge, SN; Phoenix, F; Sabroe, I; Sangha, GK; Storey, RF; Thomas, MR; West, LE	1
Coenen, MJ; Diamantea, F; Giamarellos-Bourboulis, EJ; Groothuismink, JM; Kox, M; Pickkers, P; Prekates, A; Ramakers, BP; Riksen, NP; Routsi, C; Savva, A; Sinapidis, D; Smits, P; Tasioudis, C; Toutouzas, K; van der Hoeven, JG; Vermeulen, SH	1
Abd El Galil, KH; Al-Gayyar, MM; Elsherbiny, NM	1
Bai, JY; Cao, SH; Hou, Q; Jiang, RT; Wang, DM; Wu, S; Xie, JL; Xuan, LL	1
Nylander, S; Schulz, R	1
Majetschak, M	1
Baste, JM; Begueret, H; Gay, A; Litzler, PY; Morin, JP; Noël, R; Smail, H	1
Eltzschig, HK; Ferrari, D; Gambari, R; Idzko, M; McNamee, EN	1
Quintana, FJ; Robson, S; Takenaka, MC	1
Adebiyi, MG; Blackburn, MR; Eltzschig, HK; Hu, H; Hu, X; Huang, A; Huang, D; Karmouty-Quintana, H; Kellems, RE; Le, TT; Liu, H; Luo, J; Mamenko, M; Pochynyuk, OM; Sun, K; Walters, ET; Wen, YE; Wu, H; Xia, Y; Zaika, OL; Zhang, Y; Zhao, S	1
Ahn, JM; Chang, M; Kang, SJ; Kim, YH; Lee, CW; Lee, HS; Lee, SW; Moon, DH; Oh, M; Park, DW; Park, SJ; Park, SW	1
Cornell, TT; Fleszar, AJ; McHugh, WM; Rietberg, SP; Rodenhouse, PE; Russell, WW; Shanley, TP; Sun, L	1
Cronstein, BN; Sitkovsky, M	1
Boucher, RC; Esther, CR; Muhlebach, MS; Ranganathan, S; Rosenow, T; Stick, SM; Turkovic, L	1
Alchera, E; Bardina, V; Carini, R; Imarisio, C; Novelli, F; Rolla, S; Valente, G	1
Carlstrom, M; Peleli, M	1
de Vos, P; Faas, MM; Sáez, T	1
Chiarello, DI; Gutierrez, J; Leiva, A; Pardo, F; Salsoso, R; Sobrevia, L; Toledo, F; Villalobos-Labra, R	1
Eckle, T; Eltzschig, HK; Grenz, A; Klingel, K; Osswald, H; Ravid, K; Tran, ZV; Yang, D; Zhang, H	1
Auchampach, JA; van der Hoeven, D; Wan, TC	1
Bynoe, MS; Ebisuno, Y; Mills, JH; Miyasaka, M; Takedachi, M; Tanaka, T; Thompson, LF	1
Amital, H; Bar-Yehuda, S; Barer, F; Cohen, S; Del Valle, L; Fishman, P; Gao, ZG; Jacobson, KA; Joshi, BV; Ochaion, A; Patoka, R; Perez-Liz, G	1
Black, KE; Boodoo, S; Chan-Li, Y; Collins, S; Horton, MR; Powell, JD; Scheibner, KA; Zarek, P	1
Benedek, G; Horvath, G; Kekesi, G; Nagy, E; Tuboly, G	1
Eltzschig, HK; Ngamsri, KC; Reutershan, J; Stark, S; Vollmer, I; Wagner, R	1
Barnard, A; Mantell, SJ; Stuart, EF; Trevethick, MA; Wright, KN; Yeadon, M	1
Dai, J; Houard, X; Louedec, L; Michel, JB; Philippe, M	1
Ham, J; Rees, DA	1
Broelsch, F; Cornberg, M; Jeffe, F; Manns, MP; Stegmann, KA; Wedemeyer, H	1
Coe, IR; Eltzschig, HK; Morote-Garcia, JC; Nivillac, NM; Rosenberger, P	1
Barroso, B; Geerlings, M; Hylkema, M; Postma, D; Rutgers, B; ten Hacken, N; Timens, W; Versluis, M; Willemse, B	1
Gilroy, DW; Jackson, EK; Newson, J; Rahman, F; Rajakariar, R; Sawmynaden, P; Smith, A; Yaqoob, MM	1
Colgan, SP; Ibla, JC; Khoury, J; Li, J; Liu, Q	1
Camici, PG; Harari, OA; Kaski, JC; Mason, JC; Recio-Mayoral, A; Rubens, MB	1
Ohta, A; Sitkovsky, M	1
Belikoff, B; Hatfield, S; Lukashev, D; Ohta, A; Sitkovsky, M	1
Blackburn, MR; Morschl, E; Vance, CO; Wilson, CN	1
Alves-Filho, JC; Cunha, FQ; Cunha, TM; De Oliveira, JR; Ferreira, FI; Ferreira, SH; Lima, FO; Queiroz, RH; Valério, DA; Verri, WA	1
Caruso, M; Polosa, R; Tringali, G; Varani, K	1
Colgan, SP; Eltzschig, HK; Rivera-Nieves, J	1
Atar, E; Bar-Yehuda, S; Barer, F; Castel, D; Cohen, S; Del Valle, L; Fishman, P; Ochaion, A; Patoka, R; Perez-Liz, G; Piña-Oviedo, S; Rath-Wolfson, L; Zozulya, G	1
Lawrence, T; Rodriguez-Vita, J	1
Sowa, NA; Taylor-Blake, B; Zylka, MJ	1
Dragun, D; Fuller, TF; Hegner, B; Hoff, U; Kong, L; Luft, FC; Naether, M; Nieminen-Kelhä, M; Nolting, J; Wagner, P	1
Björnsson, E; Eriksson, BM; Hedenström, H; Högman, M; Janson, C; Lúdvíksdóttir, D; Venge, P	1
Borghi, V; Kowalska, M; Nalepa, I; Pavone, F; Przewłocka, B; Roman, A; Vetulani, J	1
Gyu Jeon, S; Kim, YK; Kim, YS; Moon, HG; Oh, SY; Song Gho, Y; Tae, YM; Zhu, Z	1
Mustafa, SJ; Nadeem, A; Ponnoth, DS; Tilley, S	1
Dobson, GP	1
Li, GQ; Lu, HH; Mo, Q; Qian, J; Tang, LM; Wang, F; Wang, XH; Zhu, J; Zhu, JF	1
Fredholm, BB; Hao, JX; Li, L; Schulte, G; Wiesenfeld-Hallin, Z; Xu, XJ	1
Borea, PA; Govoni, M; Padovan, M; Trotta, F; Varani, K; Vincenzi, F	1
Csóka, B; Haskó, G	1
Hammon, JW	1
French, BA; Laubach, VE; Okusa, MD	1
Eltzschig, HK; Grenz, A; Homann, D	1
Chen, M; Huang, B; Li, F; Li, Y; Liang, Y; Tan, H; Wang, S; Yang, N; Yu, X; Zhang, L	1
Arcelus, S; Avila, MA; Banales, JM; Berasain, C; Corrales, FJ; Fernández-Barrena, MG; Gil-Puig, C; Goñi, S; Juanarena, N; Latasa, MU; Lecanda, J; Lotersztajn, S; Méndez, M; Prieto, J; Recio, JA; Rodríguez-Ortigosa, CM; Urtasun, R	1
Franke, B; Peters, WH; Pickkers, P; Ramakers, BP; Riksen, NP; Smits, P; van den Broek, P; van der Hoeven, JG	1
Zylka, MJ	1
Bramanti, P; Cipriani, S; Corti, F; Cuzzocrea, S; Esposito, E; Mazzon, E; Melani, A; Mello, T; Paterniti, I; Pedata, F	1
Fernández-Nieto, M; Madero, MF; Manso, L; Ruiz-García, M; Sastre, J	1
Antonioli, L; Blandizzi, C; Colucci, R; Fornai, M; Tuccori, M	1
Devaux, Y; Ernens, I; Haas, B; Leonard, F; Rodius, S; Rolland-Turner, M; Vausort, M; Wagner, DR	1
Eckle, T; Eltzschig, HK; Koeppen, M	1
Beceiro, S; Castrillo, A; Chawla, A; Duró, E; Fésüs, L; Kloor, D; Köröskényi, K; Ledent, CA; Pallai, A; Sarang, Z; Szondy, Z; Ucker, DS	1
Garred, P; Kim, CH; Kim, MS; Lee, BL; Lee, KJ; Ma, YJ; Ryu, KH; So, YI	1
Cronstein, BN; Williams, AJ	1
Cho, GS; Choi, IY; Choi, WJ; Hwang, S; Jeong, LS; Ju, C; Kim, WK; Lee, HW; Lee, JC	1
Csóka, B; Gause, WC; Haskó, G; Kepka-Lenhart, D; Koscsó, B; Leibovich, SJ; Morris, SM; Murray, PJ; Németh, ZH; Pacher, P; Selmeczy, Z	1
Colgan, SP; Eltzschig, HK	1
Chason, KD; Hua, X; Naselsky, WC; Patel, JY; Tilley, SL	1
Ghonem, N; Lakkis, FG; Lee, LY; Murase, N; Ozaki, KS; Pacheco-Silva, A; Pettigrew, GL; Shapiro, R; Sico, RM; Ueki, S; Yoshida, J	1
Gao, ZG; Jacobson, KA	1
Dip, R; Franchini, M; Jackson, EK; Wehrli Eser, M; Zhang, L	1
Faldyna, M; Kovaru, F; Kovaru, H; Leva, L; Matiasovic, J; Ondrackova, P	1
Antonioli, L; Awwad, O; Blandizzi, C; Colucci, R; Da Settimo, F; Fornai, M; La Motta, C; Tuccori, M	1
Bouis, D; Hayasaki, T; Hyman, MC; Petrovic-Djergovic, D; Pinsky, DJ; Ray, JJ; Visovatti, SH	1
Barletta, KE; Ley, K; Mehrad, B	1
Haskó, G; Pacher, P	2
Cronstein, BN; Reiss, AB	1
Johnston-Cox, HA; Koupenova, M; Ravid, K	1
Benight, NM; Burrin, DG; Marini, JC; Stoll, B	1
Davis, SD; Esther, CR; Johnson, R; Patel, K	1
Cronstein, BN; Frenkel, SR; He, W; Mazumder, A; Mediero, A; Wilder, T	1
Aránzazu, M; Cronstein, BN; Feig, JL; Mediero, A; Perez-Aso, M	1
Helenius, M; Jalkanen, S; Yegutkin, G	1
Burton, VJ; Butler, M; Parkinson, SJ; Pearson, R; Sanmugalingam, D; Smith, P; Watson, RP; Wilson, T	1
Acott, P; Arp, J; Cepinskas, G; Deng, JP; Garcia, B; Jevnikar, AM; Lan, Z; Liu, W; Luke, PP; Salna, M; Sener, A; Sun, T; Tran, KC	1
Brodsky, K; Ehrentraut, H; Eltzschig, HK; Grenz, A; Poth, JM	1
Bernstein, SH; Deaglio, S; Longhi, MS; Robson, SC; Serra, S	1
Colgan, SP; Ehrentraut, SF; Fennimore, B	1
Górska, A; Gołembiowska, K; Kamińska, K; Noworyta-Sokołowska, K; Wardas, J	1
Borea, PA; Corciulo, C; Gessi, S; Giacuzzo, S; Govoni, M; Merighi, S; Padovan, M; Targa, M; Varani, K; Vincenzi, F	1
Eltzschig, HK	1
Aubert, A; Blutstein, T; Haydon, PG; Laye, S; Nadjar, A	1
Hültner, L; Schmitt, E; Stassen, M	1
Anderson, R; Steel, HC; Theron, AJ; Tintinger, GR	1
Sitkovsky, MV	1
Caldwell, CC; Sitkovsky, MV; Thiel, M	1
Ham, J; Rees, DA; Scanlon, MF	1
Erikson, CJ; Galli, SJ; Koller, BH; Tilley, SL; Tsai, M; Wang, ZS; Williams, CM	1
Karasawa, A; Kusaka, H; Noji, T	1
Grünig, G	1
Banerjee, SK; Blackburn, MR; Chunn, JL; Elias, JA; Kang, MJ; Lee, CG; Young, HW; Zhu, Z	1
Bonfiglio, C; Polosa, R; Spicuzza, L	1
Nie, Y; Pypaert, M; Rabinovici, R; Su, H; Su, Y; Yang, JH; Zhao, Q	1
CARLSON, RG; TALLEY, RW	1
Boyle, DL; Firestein, GS; Moore, J; Sorkin, LS; Yang, L	1
Cronstein, BN; Haskó, G	1
Holgate, ST; Rorke, S	1
Cronstein, BN	3
Sullivan, GW	1
Henry, S; Noorbakhsh, F; Power, C; Schnermann, J; Tsutsui, S; Warren, K; Winston, BW; Yong, VW	1
Boucher, RC; Burch, LH; Picher, M	1
Apasov, S; Caldwell, C; Kojima, H; Koshiba, M; Lukashev, D; Ohta, A; Sitkovsky, MV; Thiel, M	1
Lukashev, D; Ohta, A; Sitkovsky, M	2
Ennis, M; Heaney, LG; Livingston, M	1
Fotheringham, J; Geiger, JD; Holden, C; Mayne, M; Nath, A	1
Braun, N; Buchheiser, A; Decking, UK; Ding, Z; Flögel, U; Gear, A; Gödecke, A; Huo, Y; Koszalka, P; Ley, K; Molojavyi, A; Ozüyaman, B; Schrader, J; Sévigny, J; Smith, ML; Weber, AA; Weber, C; Zernecke, A; Zimmermann, H	1
Herrero, JF; Ramos-Zepeda, G; Rosenow, S; Schröder, W	1
Mustafa, SJ; Oldenburg, PJ	1
Blackburn, MR; Molina, JG; Schnermann, J; Sun, CX; Volmer, JB; Young, HW	1
Back, SA; Rivkees, SA	1
Borenstein, T; Erdmann, AA; Foley, J; Fowler, DH; Gao, ZG; Jacobson, KA; Jung, U	1
Borgeat, P; Cadieux, JS; Dussault, AA; Laflamme, C; Leclerc, P; Ledent, C; Picard, S; Pouliot, M; St-Onge, M	1
Ohta, A; Sitkovsky, MV	1
Kalsi, K; Lavitrano, M; Lawson, C; Osborne, FN; Rose, ML; Smolenski, RT; Yacoub, MH	1
Cronstein, BN; D'Eustachio, P; Delano, DL; Desai, A; Fernandez, P; Montesinos, MC; Wilder, T; Wiltshire, T	1
Busuttil, RW; Farmer, DG; Gao, F; Ke, B; Kupiec-Weglinski, JW; Lassman, CR; Shen, XD; Tsuchihashi, S; Zhai, Y	1
Bouchard, L; Boulanger, J; Dussault, AA; Laflamme, C; McColl, SR; Pouliot, M; St-Onge, M	1
Fan, M; Jamal Mustafa, S	1
Berezina, TL; Csóka, B; Deitch, EA; Haskó, G; Jabush, J; Lu, Q; Németh, ZH; Xu, DZ; Zaets, SB	1
Blackburn, MR; Thompson, LF; Volmer, JB	1
Kolachala, VL; Merlin, D; Obertone, TS; Sitaraman, SV; Wang, L	1
Blackburn, MR; Boyden, L; Elias, JA; Flavell, RA; Homer, RJ; Lee, CG; Lifton, RP; Liu, W; Ma, B; Sun, CX; Young, HW	1
Belardinelli, L; Wu, Y; Zeng, D; Zhong, H	1
Chaimovitz, C; Douvdevani, A; Mazar, J; Nakav, S; Rogachev, B; Ziv, NY; Zlotnik, M	1
Linden, J	2
Belardinelli, L; Blackburn, MR; Chunn, JL; Mohsenin, A; Molina, JG; Morschl, E; Sun, CX; Zeng, D; Zhong, H	1
Deitch, EA; Haskó, G; Pacher, P; Vizi, ES	1
Artigiani, R; de Morais, EC; Goldenberg, A; Gonzalez, AM; Koh, IH; Matos, D; Molinari, A; Schraibman, V	1
Alvarez, C; Ferreira, A; Gatica, H; Goecke, IA; Henríquez, J; Molina, ML; Salas, K	1
Pickkers, P; Ramakers, BP; Riksen, NP; Smits, P; van der Hoeven, JG	1
Berge-Lefranc, JL; Berland, Y; Carrega, L; Charavil, A; Dussol, B; Fenouillet, E; Gerolami, V; Giaime, P; Guieu, R; Mercier, L; Ruf, J; Saadjian, A	1
Kong, LB; Li, GQ; Li, XC; Pu, LY; Sun, BC; Tang, LM; Wang, K; Wang, XH; Wang, YP; Zhang, F	1
Colgan, SP; Ibla, JC; Khoury, J; Neish, AS	1
Arant, CB; Handberg, EM; Johnson, BD; Kerensky, RA; Mankad, S; McGorray, SP; Merz, CN; Olson, MB; Pauly, DF; Pepine, CJ; Reis, SE; Sharaf, BL; Smith, KM; Sopko, G; von Mering, GO; Wessel, TR	1
Fredholm, BB	1
Cronstein, BN; Fernández, P; Montesinos, MC; Takedachi, M; Thompson, LF; Wilder, TF	1
Boucher, RC; Hirsh, AJ; Lazarowski, ER; Picher, M; Stonebraker, JR; van Heusden, CA	1
Dale, N; Gourine, AV; Gourine, VN; Llaudet, E; Poputnikov, DM; Spyer, KM	1
Dip, RG	1
Biaggioni, I; Blackburn, MR; Feoktistov, I; Goldstein, AE; Novitskiy, SV; Ryzhov, S; Zaynagetdinov, R	1
Antonioli, L; Blandizzi, C; Colucci, R; Del Tacca, M; Fornai, M; Ghisu, N; Tuccori, M	1
Palmer, TM; Trevethick, MA	1
Mustafa, SJ; Nadeem, A; Ponnoth, DS	1
Deaglio, S; Dwyer, K; Lukashev, D; Ohta, A; Robson, SC; Sitkovsky, M	1
Brown, RA; Page, CP; Spina, D	1
Blackburn, MR; Ebisuno, Y; Joachims, ML; Krahn, T; Maeda, E; McEver, RP; McGee, ST; Miyasaka, M; Murakami, S; Oohara, H; Qu, D; Takedachi, M; Tanaka, T; Thompson, LF	1
James, SJ; Nijhout, HF; Pavisic, J; Reed, MC; Thomas, RL; Ulrich, CM	1
Chaimovitz, C; Czeiger, D; Douvdevani, A; Lewis, EC; Nakav, S; Shaked, G; Sufaro, Y; Zlotnik, M	1
Polmar, SH	1
Lichtenstein, LM; Marone, G; Plaut, M; Thomas, LL	1
Condorelli, M; Marone, G; Petracca, R	1
Thomas, G	1
Martin, JG	1
Cronstein, BN; Naime, D; Ostad, E	2
de Groote, D; Devière, J; Goldman, M; Le Moine, O; Marchant, A; Schandené, L; Stordeur, P	1
Belloc, F; Boisseau, MR; Closse, C; Maurel, A; Pruvost, A; Renard, M; Seigneur, M	1
Bong, GW; Firestein, GS; Rosengren, S	1
Crimi, N; Mistretta, A; Polosa, R	1
Ienaga, K; Joh, Y; Kageyama, K; Konishi, J; Yamada, T	1
Bhagwat, SS; Jarvis, MF; Kowaluk, EA	1
Akhter, SR; Gao, XP; Hong, D; Ikezaki, H; Rubinstein, I	1
Fletcher, DS; Jacobson, MA; Koller, BH; Latour, AM; Salvatore, CA; Tilley, SL	1
Aley, KO; Levine, JD; Messing, RO; Mochly-Rosen, D	1
Anderson, R; Ramafi, G; Theron, AJ; Visser, SS	1
Hjemdahl, P; Li, N; Sollevi, A; Soop, A	1
Davis, KA; Fabian, TC; Proctor, KG; Ragsdale, DN; Trenthem, LL	1
Del Bigio, MR; Fotheringham, J; Geiger, JD; Mayne, M; Peeling, J; Power, C; Yan, HJ	1
Honkonen, EL; Kaukinen, S; Kuukasjärvi, P; Laine, S; Laurikka, J; Tarkka, M; Wei, M	1
Abunasra, H; Jayakumar, J; Kalsi, KK; Raisky, O; Slominska, EM; Smolenski, RT; Suzuki, K; Yacoub, MH	1
Badosa, F; Gelpí, E; Hotter, G; Pi, F; Prats, N; Roselló Catafau, J; Sola, A; Xaus, C	1
Bertini, R; Calvillo, L; Ghezzi, P; Latini, R; Maggioni, AP; Masson, S	1
Ellis, KM; Fozard, JR; Mazzoni, L; Tigani, B; Villela Dantas, MF	1
Wakai, A	1
Fozard, JR; Hannon, JP; Mazzoni, L; Rondeau, C; Tigani, B	1
Peck, MJ; Williams, TJ	1
Joos, G; Kips, J; Pauwels, R	1
Engler, RL	1
Church, MK; Holgate, ST; Polosa, R	2
Barrett, KE; Cohn, JA; Dharmsathaphorn, K; Huott, PA; Wasserman, SI	1
Arruzazabala, ML; Garcia, M	1
Hostetter, MK; Johnson, GM	1
Erjefält, I; Gustafsson, B; Persson, CG	1
Barnes, PJ	1

Reviews

97 review(s) available for adenosine and Innate Inflammatory Response

Article	Year
Adenosine and inflammation: it's time to (re)solve the problem. Trends in pharmacological sciences, 2022, Volume: 43, Issue:1 Topics: Adenosine; Humans; Inflammation; Inflammation Mediators	2022
The potential roles of RNA N6-methyladenosine in atherosclerosis. European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:4 Topics: Adenosine; Animals; Atherosclerosis; Inflammation; Mammals; RNA	2022
N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis. Journal of cellular physiology, 2022, Volume: 237, Issue:7 Topics: Adenosine; Animals; Carcinogenesis; Cell Transformation, Neoplastic; Humans; Immunity; Inflammation; Neoplasms; Tumor Microenvironment	2022
Anti-Inflammatory Metabolites in the Pathogenesis of Bacterial Infection. Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Adenosine; Anti-Inflammatory Agents; Bacteria; Bacterial Infections; Humans; Inflammation; Staphylococcus aureus	2022
The immunomodulatory function of adenosine in sepsis. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Animals; Immunity; Immunomodulation; Inflammation; Sepsis	2022
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression. International journal of molecular sciences, 2023, Feb-23, Volume: 24, Issue:5 Topics: Adenosine; Disease Progression; Humans; Idiopathic Pulmonary Fibrosis; Inflammation; Receptors, Purinergic P1	2023
The role of the ATP-adenosine axis in ischemic stroke. Seminars in immunopathology, 2023, Volume: 45, Issue:3 Topics: Adenosine; Adenosine Triphosphate; Humans; Inflammation; Ischemic Stroke; Signal Transduction	2023
New paradigms in purinergic receptor ligand discovery. Neuropharmacology, 2023, 06-01, Volume: 230 Topics: Adenosine; Humans; Inflammation; Ligands; Pain; Purinergic P1 Receptor Antagonists; Receptors, Purinergic	2023
Generation and Function of Non-cell-bound CD73 in Inflammation. Frontiers in immunology, 2019, Volume: 10 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Cell Communication; Cell Membrane; Extracellular Fluid; Extracellular Vesicles; Glycosylphosphatidylinositols; GPI-Linked Proteins; Humans; Inflammation; Lymphocyte Activation; Lymphocyte Subsets; Membrane Microdomains; Mice; Neoplasm Proteins; Neoplasms; Receptors, Purinergic P1; Solubility; Species Specificity; Tumor Microenvironment	2019
Methotrexate an Old Drug with New Tricks. International journal of molecular sciences, 2019, Oct-10, Volume: 20, Issue:20 Topics: Adenosine; Alarmins; Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis; Arthritis, Rheumatoid; Cytokines; Folic Acid; HMGB1 Protein; Humans; Immunity, Innate; Inflammation; Matrix Metalloproteinases; Methotrexate; NF-kappa B; Polyamines; Prostaglandins; Reactive Oxygen Species	2019
Regulation of tumor infiltrated innate immune cells by adenosine. Purinergic signalling, 2020, Volume: 16, Issue:3 Topics: Adenosine; Animals; Humans; Immunity, Innate; Inflammation; Killer Cells, Natural; Macrophages; Mast Cells; Neoplasms; Tumor Microenvironment	2020
Conversion of extracellular ATP into adenosine: a master switch in renal health and disease. Nature reviews. Nephrology, 2020, Volume: 16, Issue:9 Topics: 5'-Nucleotidase; Acute Kidney Injury; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Carcinoma, Renal Cell; Diabetic Nephropathies; Graft Rejection; Humans; Immune Tolerance; Inflammation; Kidney Diseases; Kidney Neoplasms; Kidney Transplantation; Macrophages; Polycystic Kidney Diseases; Receptors, Purinergic P1; Receptors, Purinergic P2; Renal Insufficiency, Chronic; Reperfusion Injury; Signal Transduction; T-Lymphocytes, Regulatory	2020
The Adenosine System at the Crossroads of Intestinal Inflammation and Neoplasia. International journal of molecular sciences, 2020, Jul-18, Volume: 21, Issue:14 Topics: Adenosine; Animals; Colitis-Associated Neoplasms; Colorectal Neoplasms; Dextran Sulfate; Humans; Immune System; Inflammation; Inflammatory Bowel Diseases; Receptors, Purinergic P1; Signal Transduction	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
[Progress on role of extracellular ATP and its metabolite adenosine in immunoregulation: Review]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology, 2020, Volume: 36, Issue:12 Topics: Adenosine; Adenosine Triphosphate; Humans; Immunity; Inflammation; Signal Transduction	2020
Adenosine at the Interphase of Hypoxia and Inflammation in Lung Injury. Frontiers in immunology, 2020, Volume: 11 Topics: Acute Lung Injury; Adenosine; Disease Management; Disease Susceptibility; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Inflammation; Molecular Targeted Therapy; Receptors, Purinergic P1; Respiratory Distress Syndrome; Signal Transduction	2020
Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils. International journal of molecular sciences, 2021, May-22, Volume: 22, Issue:11 Topics: Adenosine; Animals; Cannabinoids; Cannabis; Diet; Endocannabinoids; Fatty Acids, Unsaturated; Homeostasis; Humans; Inflammation; Lipid Metabolism; Oxidative Stress; Plant Extracts; Signal Transduction; TRPV Cation Channels	2021
Adenosine and Inflammation: Here, There and Everywhere. International journal of molecular sciences, 2021, Jul-19, Volume: 22, Issue:14 Topics: Adenosine; Animals; Humans; Inflammation; Inflammatory Bowel Diseases; Ligands; Lung Diseases; Models, Biological; Models, Immunological; Neoplasms; Neuroimmunomodulation; Osteoarthritis; Receptors, Purinergic P1; Rheumatic Diseases	2021
Role of adenosine signaling in the pathogenesis of breast cancer. Journal of cellular physiology, 2018, Volume: 233, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Humans; Inflammation; MCF-7 Cells; Neoplasm Metastasis; Receptors, Adenosine A2; Signal Transduction; Tumor Microenvironment	2018
Purinergic signalling links mechanical breath profile and alveolar mechanics with the pro-inflammatory innate immune response causing ventilation-induced lung injury. Purinergic signalling, 2017, Volume: 13, Issue:3 Topics: Adenosine; Animals; Humans; Immunity, Innate; Inflammation; Lung Injury; Purinergic Agents; Receptors, Purinergic	2017
Therapeutic potentials of adenosine receptors agonists and antagonists in colitis; Current status and perspectives. Journal of cellular physiology, 2018, Volume: 233, Issue:4 Topics: Adenosine; Animals; Colitis; Humans; Inflammation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Signal Transduction	2018
Tackling Chronic Pain and Inflammation through the Purinergic System. Current medicinal chemistry, 2018, Volume: 25, Issue:32 Topics: Adenosine; Adenosine Triphosphate; Analgesics; Animals; Anti-Inflammatory Agents; Chronic Pain; Humans; Inflammation; Purinergic Agonists; Purinergic Antagonists; Receptors, Purinergic; Signal Transduction	2018
The hypoxia-adenosine link during inflammation. Journal of applied physiology (Bethesda, Md. : 1985), 2017, Nov-01, Volume: 123, Issue:5 Topics: Acute Lung Injury; Adenosine; Animals; Basic Helix-Loop-Helix Transcription Factors; Clinical Trials as Topic; Heart Diseases; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Inflammation; Inflammatory Bowel Diseases; Signal Transduction	2017
CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans. Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Clinical Trials as Topic; Disease Models, Animal; GPI-Linked Proteins; Humans; Inflammation; Joint Diseases; Mice, Knockout; Molecular Targeted Therapy; Neoplasms; Phenotype; Species Specificity; Thrombophilia; Tunica Media; Vascular Calcification; Vascular Diseases; Vascular Remodeling	2019
Adenosine kinase and cardiovascular fetal programming in gestational diabetes mellitus. Biochimica et biophysica acta. Molecular basis of disease, 2020, 02-01, Volume: 1866, Issue:2 Topics: Adenosine; Adenosine Kinase; Animals; Cardiovascular System; Diabetes Mellitus; Diabetes, Gestational; DNA Methylation; Endothelium; Epigenomics; Female; Fetal Development; Gene Expression Regulation; Humans; Inflammation; Mice; Placenta; Pregnancy	2020
Tinkering with targeting nucleotide signaling for control of intracellular Leishmania parasites. Cytokine, 2019, Volume: 119 Topics: Adenosine; Adenosine Triphosphate; Animals; Humans; Inflammation; Leishmania; Macrophages; Nucleotides; Parasites; Signal Transduction	2019
Role and Function of Adenosine and its Receptors in Inflammation, Neuroinflammation, IBS, Autoimmune Inflammatory Disorders, Rheumatoid Arthritis and Psoriasis. Current pharmaceutical design, 2019, Volume: 25, Issue:26 Topics: Adenosine; Arthritis, Rheumatoid; Autoimmune Diseases; Humans; Inflammation; Irritable Bowel Syndrome; Psoriasis; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1	2019
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer immunology, immunotherapy : CII, 2014, Volume: 63, Issue:1 Topics: Adenosine; Animals; CD4-Positive T-Lymphocytes; Chemoradiotherapy; Dinoprostone; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Inflammation; Lymphocyte Subsets; Neoplasms; T-Lymphocytes, Regulatory; Tumor Escape; Tumor Microenvironment	2014
Immunity, inflammation and cancer: a leading role for adenosine. Nature reviews. Cancer, 2013, Volume: 13, Issue:12 Topics: Adenosine; Animals; Cell Proliferation; Humans; Inflammation; Inflammation Mediators; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neoplasms; Receptors, Purinergic P1; Tumor Microenvironment	2013
Adenosine and inflammation: what's new on the horizon? Drug discovery today, 2014, Volume: 19, Issue:8 Topics: Adenosine; Allosteric Regulation; Animals; Humans; Inflammation; Ligands; Receptors, Purinergic P1	2014
Purinergic receptors in ocular inflammation. Mediators of inflammation, 2014, Volume: 2014 Topics: Adenosine; Animals; Dinucleoside Phosphates; Eye; Humans; Inflammation; Receptors, Purinergic	2014
Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization. Biomolecules, 2015, May-05, Volume: 5, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; Helicobacter Infections; Immunity, Innate; Inflammation; Mice; Salmonella Infections	2015
Effects of P2Y12 receptor antagonists beyond platelet inhibition--comparison of ticagrelor with thienopyridines. British journal of pharmacology, 2016, Volume: 173, Issue:7 Topics: Adenosine; Animals; Atherosclerosis; Blood Platelets; Cardiotonic Agents; Cardiovascular Physiological Phenomena; Equilibrative Nucleoside Transporter 1; Humans; Inflammation; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thienopyridines; Ticagrelor	2016
Purinergic Signaling During Immune Cell Trafficking. Trends in immunology, 2016, Volume: 37, Issue:6 Topics: Adenosine; Adenosine Triphosphate; Animals; Apyrase; Cell Communication; Cell Movement; Chemokines; Humans; Inflammation; Leukocytes; Lymphocyte Activation; Nucleotidases; Receptors, Purinergic; Signal Transduction	2016
Regulation of the T Cell Response by CD39. Trends in immunology, 2016, Volume: 37, Issue:7 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Autoimmune Diseases; Autoimmunity; Gene-Environment Interaction; Humans; Immune Tolerance; Infections; Inflammation; Lymphocyte Activation; Neoplasms; T-Lymphocytes	2016
Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases. Nature reviews. Rheumatology, 2017, Volume: 13, Issue:1 Topics: Adaptive Immunity; Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Fibrosis; Gene Dosage; Humans; Immunity, Innate; Inflammation; Receptor, Adenosine A2A; Receptors, Purinergic P1; Rheumatic Diseases; T-Lymphocytes	2017
Adenosine signaling in diabetes mellitus and associated cardiovascular and renal complications. Molecular aspects of medicine, 2017, Volume: 55 Topics: Adenosine; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Humans; Inflammation; Insulin; Insulin Resistance; Insulin-Secreting Cells; Muscle, Skeletal; Signal Transduction	2017
Extracellular ATP and adenosine: The Yin and Yang in immune responses? Molecular aspects of medicine, 2017, Volume: 55 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Antigens, CD; Apyrase; Endothelial Cells; Humans; Immunity, Cellular; Inflammation; Receptors, Purinergic P1; Receptors, Purinergic P2X; Receptors, Purinergic P2Y	2017
Molecular implications of adenosine in obesity. Molecular aspects of medicine, 2017, Volume: 55 Topics: Adenosine; Adipocytes; Adipogenesis; Cell Differentiation; Humans; Inflammation; Insulin Resistance; Lipolysis; Obesity; Receptors, Purinergic P1; Thermogenesis	2017
Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions. British journal of pharmacology, 2008, Volume: 155, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Inflammation; Lung; Pulmonary Disease, Chronic Obstructive	2008
The adenosine a2b receptor: its role in inflammation. Endocrine, metabolic & immune disorders drug targets, 2008, Volume: 8, Issue:4 Topics: Adenosine; Animals; Humans; Inflammation; Receptor, Adenosine A2B	2008
The adenosinergic immunomodulatory drugs. Current opinion in pharmacology, 2009, Volume: 9, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Cell Hypoxia; Humans; Immunosuppressive Agents; Inflammation; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Signal Transduction	2009
The antihypoxia-adenosinergic pathogenesis as a result of collateral damage by overactive immune cells. Journal of leukocyte biology, 2009, Volume: 86, Issue:3 Topics: Acute Lung Injury; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Disease Models, Animal; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Mice; Mice, Mutant Strains; Oxygen; Oxygen Consumption; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Respiratory Distress Syndrome; T-Lymphocytes, Regulatory	2009
Adenosine receptors and inflammation. Handbook of experimental pharmacology, 2009, Issue:193 Topics: Adenosine; Animals; Dendritic Cells; Endothelial Cells; Humans; Inflammation; Lymphocytes; Neutrophils; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1	2009
Adenosine and adenosine receptors: their contribution to airway inflammation and therapeutic potential in asthma. Current medicinal chemistry, 2009, Volume: 16, Issue:29 Topics: Adenosine; Anti-Asthmatic Agents; Asthma; Drug Delivery Systems; Humans; Inflammation; Molecular Structure; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1	2009
Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammation. Expert opinion on therapeutic targets, 2009, Volume: 13, Issue:11 Topics: Adenosine; Animals; Drug Delivery Systems; Humans; Hypoxia-Inducible Factor 1; Inflammation; Intestinal Diseases; Ischemia; Receptor, Adenosine A2B; Signal Transduction	2009
The resolution of inflammation and cancer. Cytokine & growth factor reviews, 2010, Volume: 21, Issue:1 Topics: Adenosine; Animals; Cytokines; Humans; Inflammation; Inflammation Mediators; Lipids; Models, Immunological; Neoplasms	2010
The role of adenosine receptors in rheumatoid arthritis. Autoimmunity reviews, 2010, Volume: 10, Issue:2 Topics: Adenosine; Animals; Arthritis, Rheumatoid; Humans; Inflammation; Purinergic Agonists; Receptors, Purinergic P1	2010
Targeting of adenosine receptors in ischemia-reperfusion injury. Expert opinion on therapeutic targets, 2011, Volume: 15, Issue:1 Topics: Adenosine; Animals; Drug Delivery Systems; Drug Design; Humans; Inflammation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Reperfusion Injury	2011
Extracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxidants & redox signaling, 2011, Oct-15, Volume: 15, Issue:8 Topics: Adenosine; Animals; Humans; Hypoxia; Inflammation; Ischemia; Signal Transduction	2011
Pain-relieving prospects for adenosine receptors and ectonucleotidases. Trends in molecular medicine, 2011, Volume: 17, Issue:4 Topics: 5'-Nucleotidase; Acid Phosphatase; Acupuncture Therapy; Adenosine; Adenosine Monophosphate; Analgesics; Animals; Humans; Hyperalgesia; Inflammation; Neuralgia; Nociceptors; Protein Tyrosine Phosphatases; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Recombinant Proteins	2011
Interplay of hypoxia and A2B adenosine receptors in tissue protection. Advances in pharmacology (San Diego, Calif.), 2011, Volume: 61 Topics: Adenosine; Animals; Humans; Hypoxia; Inflammation; Organ Specificity; Receptor, Adenosine A2B; Signal Transduction	2011
Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery. Annual review of physiology, 2012, Volume: 74 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Extracellular Space; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Immunity, Mucosal; Inflammation; Intestinal Diseases; Intestinal Mucosa; Irritable Bowel Syndrome; Mice; Nucleotides; Procollagen-Proline Dioxygenase; Receptors, Purinergic P1; Signal Transduction	2012
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders. Current drug targets, 2012, Volume: 13, Issue:6 Topics: Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Animals; Anti-Inflammatory Agents; Drug Design; Humans; Immune System; Inflammation; Receptors, Purinergic P1	2012
Regulation of neutrophil function by adenosine. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Animals; Cell Adhesion; Cell Degranulation; Chemotaxis, Leukocyte; Humans; Inflammation; Neutrophil Activation; Neutrophils; Phagocytosis; Receptors, Purinergic P1; Respiratory Burst; Signal Transduction; Transendothelial and Transepithelial Migration	2012
Regulation of macrophage function by adenosine. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Animals; Cell Differentiation; Humans; Inflammation; Macrophage Activation; Macrophages; Neoplasms; Neovascularization, Physiologic; Osteoclasts; Phagocytosis; Receptors, Purinergic P1; Signal Transduction; Vascular Diseases	2012
Regulation of foam cells by adenosine. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Atherosclerosis; Cholesterol; Cyclooxygenase Inhibitors; Foam Cells; Homeostasis; Humans; Hypoxia-Inducible Factor 1; Inflammation; Receptors, Purinergic P1; Scavenger Receptors, Class E; Signal Transduction	2012
A2 adenosine receptors and vascular pathologies. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Animals; Atherosclerosis; Blood Vessels; Humans; Inflammation; Receptors, Adenosine A2; Signal Transduction; Thrombosis; Vascular Diseases	2012
Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:2 Topics: Adenosine; Animals; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Inflammation; Ischemia; Signal Transduction; Transcription, Genetic	2013
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:2 Topics: Adenosine; Animals; Autoimmune Diseases; Humans; Hydrolases; Inflammation; Neoplasms; Reperfusion Injury; Respiratory Tract Diseases; Sepsis	2013
Adenosine and gastrointestinal inflammation. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:2 Topics: Adenosine; Animals; Gastrointestinal Diseases; Humans; Inflammation; Intestinal Mucosa	2013
Classical and alternative pathways of mast cell activation. Critical reviews in immunology, 2002, Volume: 22, Issue:2 Topics: Adenosine; Animals; Cell Degranulation; Disease Models, Animal; Endothelin-1; Gene Expression Regulation; Immune System; Immunoglobulin G; Infections; Inflammation; Mast Cells; Neurosecretory Systems; Receptors, IgE	2002
Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo. Biochemical pharmacology, 2003, Feb-15, Volume: 65, Issue:4 Topics: Adenosine; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents; Cyclic AMP; Humans; Inflammation; Receptor, Adenosine A2A; Receptors, Purinergic P1; Signal Transduction	2003
The critical role of adenosine A2A receptors in downregulation of inflammation and immunity in the pathogenesis of infectious diseases. Microbes and infection, 2003, Volume: 5, Issue:6 Topics: Adenosine; Animals; Communicable Diseases; Humans; Immunity, Innate; Inflammation; Receptor, Adenosine A2A; Receptors, Purinergic P1; Sepsis	2003
Adenosine signalling pathways in the pituitary gland: one ligand, multiple receptors. The Journal of endocrinology, 2003, Volume: 177, Issue:3 Topics: Adenosine; Cell Division; Humans; Inflammation; Interleukin-6; Neoplasms; Pituitary Gland, Anterior; Pituitary Hormones; Receptors, Purinergic P1; Signal Transduction	2003
[Pharmacological study on the effects of the adenosine uptake inhibitor KF24345 on inflammatory diseases]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica, 2003, Volume: 122, Issue:2 Topics: Acute Disease; Adenosine; Animals; Depression, Chemical; Erythrocytes; Glomerulonephritis; Humans; Inflammation; Leukopenia; Lipopolysaccharides; Mice; Neurotransmitter Uptake Inhibitors; Pancreatitis; Pyrimidinones; Quinazolines; Tumor Necrosis Factor-alpha	2003
Research applications and implications of adenosine in diseased airways. Trends in pharmacological sciences, 2003, Volume: 24, Issue:8 Topics: Adenosine; Administration, Inhalation; Animals; Asthma; Bronchoconstriction; Diagnosis, Differential; Humans; Inflammation; Pulmonary Disease, Chronic Obstructive; Vasodilator Agents	2003
Adenosine: an endogenous regulator of innate immunity. Trends in immunology, 2004, Volume: 25, Issue:1 Topics: Adenosine; Animals; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Signal Transduction	2004
Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease. American journal of respiratory medicine : drugs, devices, and other interventions, 2002, Volume: 1, Issue:2 Topics: Adenosine; Asthma; Bronchoconstriction; Humans; Inflammation; Mast Cells; Pulmonary Disease, Chronic Obstructive; Receptors, Purinergic P1	2002
Adenosine receptors and wound healing. TheScientificWorldJournal, 2004, Jan-16, Volume: 4 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Endothelium, Vascular; Inflammation; Mice; Neovascularization, Physiologic; Purinergic P1 Receptor Agonists; Wound Healing	2004
Adenosine A2A receptor agonists as anti-inflammatory agents. Current opinion in investigational drugs (London, England : 2000), 2003, Volume: 4, Issue:11 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Humans; Inflammation; Molecular Structure	2003
Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annual review of immunology, 2004, Volume: 22 Topics: Adenosine; Animals; DNA-Binding Proteins; Humans; Hypoxia; Immunity, Cellular; Inflammation; Nuclear Proteins; Receptors, Adenosine A2; Signal Transduction	2004
Targeting hypoxia--A(2A) adenosine receptor-mediated mechanisms of tissue protection. Drug discovery today, 2004, May-01, Volume: 9, Issue:9 Topics: Adenosine; Animals; Cell Hypoxia; Cyclic AMP; Down-Regulation; Humans; Inflammation; Receptors, Adenosine A2; Signal Transduction	2004
Adenosine, inflammation and asthma--a review. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2004, Volume: 53, Issue:5 Topics: Adenosine; Animals; Asthma; Basophils; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoconstrictor Agents; Humans; Inflammation; Mast Cells; Receptors, Purinergic P1	2004
Emerging concepts in periventricular white matter injury. Seminars in perinatology, 2004, Volume: 28, Issue:6 Topics: Adenosine; Animals; Biomarkers; Disease Models, Animal; Humans; Hypoxia-Ischemia, Brain; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Inflammation; Leukomalacia, Periventricular; Microglia; Neurons; Oligodendroglia; Oxidative Stress; Reactive Nitrogen Species; Reactive Oxygen Species; Risk Factors; Stem Cells	2004
Shaping of monocyte and macrophage function by adenosine receptors. Pharmacology & therapeutics, 2007, Volume: 113, Issue:2 Topics: Adenosine; Animals; Cell Differentiation; Cell Proliferation; Cytokines; Humans; Inflammation; Macrophages; Nitric Oxide; Phagocytosis; Receptors, Purinergic P1; Respiratory Burst; Thromboplastin; Vascular Endothelial Growth Factor A	2007
Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell death and differentiation, 2007, Volume: 14, Issue:7 Topics: Adenosine; Animals; Cytoprotection; Humans; Hypoxia; Inflammation; Ischemic Preconditioning; Oxidative Stress; Receptors, Purinergic P1; Regeneration; Signal Transduction	2007
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer metastasis reviews, 2007, Volume: 26, Issue:2 Topics: Adenosine; Cell Hypoxia; Humans; Inflammation; Neoplasms; Receptors, Purinergic P1; T-Lymphocytes	2007
Adenosine receptor modulation: potential implications in veterinary medicine. Veterinary journal (London, England : 1997), 2009, Volume: 179, Issue:1 Topics: Adenosine; Animals; Asthma; Bronchoconstriction; Cat Diseases; Cats; Horse Diseases; Horses; Inflammation; Pulmonary Disease, Chronic Obstructive; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction	2009
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflammatory bowel diseases, 2008, Volume: 14, Issue:4 Topics: Adenosine; Animals; Enteric Nervous System; Gastrointestinal Motility; Humans; Immunity, Cellular; Inflammation; Inflammatory Bowel Diseases; Intestinal Mucosa; Intestines; Purinergic P1 Receptor Antagonists	2008
Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction. British journal of pharmacology, 2008, Volume: 153 Suppl 1 Topics: Adenosine; Adenosine A2 Receptor Agonists; Anti-Inflammatory Agents; Extracellular Space; Humans; Immunity; Immunosuppressive Agents; Inflammation	2008
A2A receptors in inflammation and injury: lessons learned from transgenic animals. Journal of leukocyte biology, 2008, Volume: 83, Issue:3 Topics: Adenosine; Animals; Animals, Genetically Modified; Humans; Immunity; Inflammation; Models, Biological; Receptors, Adenosine A2; Receptors, Purinergic P1; Signal Transduction; Wounds and Injuries	2008
Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells. British journal of pharmacology, 2008, Volume: 153 Suppl 1 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Extracellular Space; Humans; Immunotherapy; Inflammation; Receptors, G-Protein-Coupled; T-Lymphocytes, Regulatory	2008
Adenosine receptors and asthma. British journal of pharmacology, 2008, Volume: 153 Suppl 1 Topics: Adenosine; Animals; Anti-Asthmatic Agents; Asthma; Bronchoconstriction; Humans; Inflammation; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1	2008
Pharmacological modification of immunoregulatory activity of lymphocytes: facts and potential. Survey of immunologic research, 1984, Volume: 3, Issue:4 Topics: Adenosine; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Cell Differentiation; Cyclic AMP; Fatty Acids, Unsaturated; Histamine; Immune System Diseases; Immunosuppression Therapy; Inflammation; Lymphocyte Cooperation; Lymphokines; Macrophages; Suppressor Factors, Immunologic; T-Lymphocytes	1984
[Animal models of bronchial hyperreactivity]. Revue des maladies respiratoires, 1994, Volume: 11, Issue:2 Topics: Adenosine; Animals; Asthma; Bradykinin; Bronchial Hyperreactivity; Bronchial Provocation Tests; Chronic Disease; Cytokines; Dextrans; Disease Models, Animal; Dogs; Guinea Pigs; Inflammation; Leukotrienes; Lipoxygenase; Mast Cells; Ozone; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Tachykinins	1994
A novel approach to the development of anti-inflammatory agents: adenosine release at inflamed sites. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 1995, Volume: 43, Issue:1 Topics: Adenosine; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Humans; Inflammation; Methotrexate; Sulfasalazine	1995
Adenosine, an endogenous anti-inflammatory agent. Journal of applied physiology (Bethesda, Md. : 1985), 1994, Volume: 76, Issue:1 Topics: Adenosine; Animals; Humans; Inflammation; Neutrophils; Receptors, Purinergic P1	1994
Purine derivatives in the study of allergic inflammation in respiratory diseases. Allergy, 1997, Volume: 52, Issue:34 Suppl Topics: Adenosine; Animals; Asthma; Bronchi; Bronchial Provocation Tests; Bronchoconstriction; Guinea Pigs; Humans; Inflammation; Purine Nucleosides; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal	1997
Adenosine kinase inhibitors. Current pharmaceutical design, 1998, Volume: 4, Issue:5 Topics: Adenosine; Adenosine Kinase; Animals; Chemistry, Pharmaceutical; Enzyme Inhibitors; Humans; In Vitro Techniques; Inflammation; Pain; Wounds and Injuries	1998
Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annual review of pharmacology and toxicology, 2001, Volume: 41 Topics: Adenosine; Animals; Humans; Inflammation; Receptors, Purinergic P1; Reperfusion Injury	2001
Cardiac protection by pharmacological modulation of inflammation. Expert opinion on investigational drugs, 2001, Volume: 10, Issue:11 Topics: Adenosine; Animals; Bacterial Infections; Cardiovascular Agents; Complement System Proteins; Cytokines; Enzyme Inhibitors; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Matrix Metalloproteinase Inhibitors; Neutrophils; Reactive Oxygen Species	2001
Processes and bronchial hyperresponsiveness. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1991, Volume: 21 Suppl 1 Topics: Adenosine; Animals; Asthma; Bronchi; Humans; Inflammation; Neurokinin A; Neuropeptides; Rats	1991
Adenosine: a positive modulator of airway inflammation in asthma. Annals of the New York Academy of Sciences, 1991, Volume: 629 Topics: Adenosine; Animals; Asthma; Bronchoconstriction; Humans; Inflammation; Mast Cells; Respiratory Physiological Phenomena; Respiratory System	1991
Adenosine as a pro-inflammatory mediator in asthma. Pulmonary pharmacology, 1989, Volume: 2, Issue:1 Topics: Adenosine; Animals; Asthma; Humans; Inflammation	1989
Xanthines--symptomatic or prophylactic in asthma? Agents and actions. Supplements, 1988, Volume: 23 Topics: Adenosine; Animals; Asthma; Bronchi; Humans; In Vitro Techniques; Inflammation; Muscle Contraction; T-Lymphocytes; Xanthines	1988
Inflammatory mechanisms and nocturnal asthma. The American journal of medicine, 1988, Jul-29, Volume: 85, Issue:1B Topics: Adenosine; Asthma; Blood Platelets; Circadian Rhythm; Eosinophils; Epithelium; Histamine; Humans; Inflammation; Lymphocytes; Macrophages; Mast Cells; Neutrophils; Platelet Activating Factor; Prostaglandins; SRS-A	1988

Trials

11 trial(s) available for adenosine and Innate Inflammatory Response

Article	Year
Methotrexate effects on adenosine receptor expression in peripheral monocytes of persons with type 2 diabetes and cardiovascular disease. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2022, Volume: 70, Issue:6 Topics: Adenosine; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Gene Expression; Humans; Inflammation; Leukocytes, Mononuclear; Methotrexate; Monocytes; Myocardial Infarction; Receptors, Purinergic P1	2022
Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease. Vascular pharmacology, 2023, Volume: 148 Topics: Adenosine; Clopidogrel; Female; Humans; Inflammation; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Renal Insufficiency, Chronic; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome	2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
A randomised trial on the effect of anti-platelet therapy on the systemic inflammatory response in human endotoxaemia. Thrombosis and haemostasis, 2017, 08-30, Volume: 117, Issue:9 Topics: Adenosine; Administration, Intravenous; Adolescent; Adult; Aspirin; Cells, Cultured; Clopidogrel; Cytokines; Drug Therapy, Combination; Endotoxemia; Endotoxins; Healthy Volunteers; Humans; Inflammation; Inflammation Mediators; Male; Netherlands; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult	2017
Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses. Thrombosis and haemostasis, 2015, Volume: 113, Issue:5 Topics: Adenosine; Adenosine Diphosphate; Adult; Blood Platelets; Cross-Over Studies; Cytokines; Double-Blind Method; Humans; Inflammation; Leukocytes, Mononuclear; Ligands; Lipopolysaccharides; Male; Monocytes; Phagocytosis; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Function Tests; RNA, Messenger; Ticagrelor; Toll-Like Receptor 2; Toll-Like Receptor 4; Young Adult	2015
Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model. Arteriosclerosis, thrombosis, and vascular biology, 2015, Volume: 35, Issue:12 Topics: Adenosine; Anti-Inflammatory Agents; Biomarkers; Blood Platelets; Chemotaxis, Leukocyte; Clopidogrel; Cytokines; Endotoxins; England; Female; Fibrin Fibrinogen Degradation Products; Humans; Inflammation; Inflammation Mediators; Male; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Young Adult	2015
Similar Impact of Clopidogrel or Ticagrelor on Carotid Atherosclerotic Plaque Inflammation. Clinical cardiology, 2016, Volume: 39, Issue:11 Topics: Adenosine; Aged; Anti-Inflammatory Agents; Carotid Arteries; Carotid Stenosis; Clopidogrel; Female; Fluorodeoxyglucose F18; Humans; Inflammation; Male; Middle Aged; Plaque, Atherosclerotic; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Purinergic P2Y Receptor Antagonists; Radiopharmaceuticals; Republic of Korea; Severity of Illness Index; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome	2016
Circulating adenosine increases during human experimental endotoxemia but blockade of its receptor does not influence the immune response and subsequent organ injury. Critical care (London, England), 2011, Volume: 15, Issue:1 Topics: Adenosine; AMP Deaminase; Caffeine; Double-Blind Method; Endotoxemia; Escherichia coli; Humans; Immunity, Innate; Inflammation; Kidney; Lipopolysaccharides; Male; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1	2011
Impairment of adenosine A3 receptor activity disrupts neutrophil migratory capacity and impacts innate immune function in vivo. European journal of immunology, 2012, Volume: 42, Issue:12 Topics: Adenosine; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Animals; Chemotaxis; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Immunity, Innate; Inflammation; Mice; Mice, Knockout; Neutrophils; Quinazolines; Receptor, Adenosine A3; Triazoles; Up-Regulation	2012
Multi-cellular activation in vivo by endotoxin in humans--limited protection by adenosine infusion. Thrombosis and haemostasis, 2000, Volume: 84, Issue:3 Topics: Adenosine; Adult; Cell Adhesion; Cross-Over Studies; Double-Blind Method; Endotoxins; Hematologic Tests; Hemodynamics; Humans; Inflammation; Infusions, Intravenous; Leukocytes; Macrophage-1 Antigen; Male; P-Selectin; Peptide Fragments; Placebos; Platelet Activation; Prothrombin; von Willebrand Factor	2000
Cardioprotective effect of adenosine pretreatment in coronary artery bypass grafting. Chest, 2001, Volume: 120, Issue:3 Topics: Adenosine; Aged; Cardiovascular Agents; Coronary Artery Bypass; Cytokines; Heart; Hemodynamics; Humans; Inflammation; Leukocyte Count; Male; Middle Aged; Myocardial Reperfusion Injury; Prospective Studies	2001

Other Studies

256 other study(ies) available for adenosine and Innate Inflammatory Response

Article	Year
Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. Current protocols in cytometry, 2010, Volume: Chapter 13 Topics: Animals; Biotinylation; Flow Cytometry; Fluorescence Resonance Energy Transfer; Green Fluorescent Proteins; High-Throughput Screening Assays; Humans; Inflammation; Kinetics; Microspheres; Peptide Hydrolases; Peptides; Reproducibility of Results; Temperature	2010
METTL14 aggravates podocyte injury and glomerulopathy progression through N Cell death & disease, 2021, 09-27, Volume: 12, Issue:10 Topics: Adenosine; Animals; Apoptosis; Autophagy; Cytoprotection; Diabetic Nephropathies; Disease Progression; Down-Regulation; Doxorubicin; Gene Silencing; Glycation End Products, Advanced; Inflammation; Male; Methyltransferases; Mice, Inbred C57BL; Models, Biological; Podocytes; RNA, Messenger; Sirtuin 1; Up-Regulation	2021
CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nature communications, 2021, 10-08, Volume: 12, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Autoimmunity; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Proliferation; Extracellular Vesicles; GPI-Linked Proteins; Humans; Immunosuppression Therapy; Inflammation; Lymphocyte Activation; Mice; T-Lymphocytes; T-Lymphocytes, Regulatory	2021
CF101 alleviates OA progression and inhibits the inflammatory process via the AMP/ATP/AMPK/mTOR axis. Bone, 2022, Volume: 155 Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Animals; Cartilage, Articular; Chondrocytes; Collagen Type II; Disease Models, Animal; Inflammation; Osteoarthritis; Rats; TOR Serine-Threonine Kinases	2022
Adenosine restrains ILC2-driven allergic airway inflammation via A2A receptor. Mucosal immunology, 2022, Volume: 15, Issue:2 Topics: Adenosine; Animals; Hypersensitivity; Immunity, Innate; Inflammation; Interleukin-33; Lung; Lymphocytes; Mice; Receptor, Adenosine A2A	2022
Comparison of intra-articular administration of adenosine, lidocaine and magnesium solution and tranexamic acid for alleviating postoperative inflammation and joint fibrosis in an experimental model of knee arthroplasty. Journal of orthopaedic surgery and research, 2021, Dec-20, Volume: 16, Issue:1 Topics: Adenosine; Administration, Intravenous; Animals; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Fibrosis; Inflammation; Injections, Intra-Articular; Interleukin-10; Interleukin-12; Lidocaine; Magnesium; Male; Models, Theoretical; Osteoarthritis, Knee; Postoperative Hemorrhage; Rats; Rats, Sprague-Dawley; Tranexamic Acid	2021
Hsa_circ_0004287 inhibits macrophage-mediated inflammation in an N The Journal of allergy and clinical immunology, 2022, Volume: 149, Issue:6 Topics: Adenosine; Animals; Dermatitis, Atopic; Humans; Inflammation; Leukocytes, Mononuclear; Macrophages; Mice; MicroRNAs; Psoriasis; RNA, Circular; RNA, Long Noncoding	2022
Amniotic fluid stem cell-derived extracellular vesicles are independent metabolic units capable of modulating inflammasome activation in THP-1 cells. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:4 Topics: Adenosine; Amniotic Fluid; Anti-Inflammatory Agents; Extracellular Vesicles; Humans; Inflammasomes; Inflammation; Monocytes; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Stem Cells; THP-1 Cells	2022
Inactivation of AUF1 in Myeloid Cells Protects From Allergic Airway and Tumor Infiltration and Impairs the Adenosine-Induced Polarization of Pro-Angiogenic Macrophages. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Animals; Hypersensitivity; Inflammation; Lung; Macrophages; Mice; Myeloid Cells; Neoplasms; RNA, Messenger	2022
N Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Animals; Cattle; Epithelial Cells; Escherichia coli; Escherichia coli Infections; Female; Humans; Inflammation; Mastitis; RNA, Circular; RNA, Messenger; Staphylococcal Infections; Staphylococcus aureus	2022
RNA m6A reader YTHDF1 facilitates inflammation via enhancing NLRP3 translation. Biochemical and biophysical research communications, 2022, 08-06, Volume: 616 Topics: Adenosine; Animals; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; RNA; RNA-Binding Proteins	2022
WTAP-mediated N Cellular & molecular biology letters, 2022, Jun-27, Volume: 27, Issue:1 Topics: Adenosine; Animals; Cell Cycle Proteins; Cytokines; Diabetes Mellitus; Diabetic Nephropathies; Histone Acetyltransferases; Humans; Inflammasomes; Inflammation; Kidney; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; RNA Splicing Factors; RNA, Messenger	2022
Myocardial perfusion reserve in patients with chronic hepatitis C before and after direct-acting antiviral treatment-a pilot study. Clinical physiology and functional imaging, 2022, Volume: 42, Issue:6 Topics: Adenosine; Antiviral Agents; Biomarkers; Hepatitis C, Chronic; Humans; Inflammation; Middle Aged; Perfusion; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies	2022
Cell-specific Deletion of NLRP3 Inflammasome Identifies Myeloid Cells as Key Drivers of Liver Inflammation and Fibrosis in Murine Steatohepatitis. Cellular and molecular gastroenterology and hepatology, 2022, Volume: 14, Issue:4 Topics: Adenosine; Amino Acids; Animals; Caspases; Choline; Hepatitis; Humans; Inflammasomes; Inflammation; Interleukin-1beta; Lipopolysaccharides; Liver Cirrhosis; Mice; Mice, Knockout; Myeloid Cells; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Polyphosphates	2022
Istradefylline, an adenosine A2a receptor antagonist, inhibits the CD4 Immunological medicine, 2022, Volume: 45, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; CD4-Positive T-Lymphocytes; Humans; Inflammation; Interleukin-17; Interleukin-8; Leukocytes, Mononuclear; Mice; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A2A; T-Lymphocytes	2022
ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation. Nature, 2022, Volume: 607, Issue:7920 Topics: Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Deaminase; Animals; Apoptosis; Autoimmune Diseases of the Nervous System; Caspase 8; Humans; Inflammation; Inosine; Intestines; Mice; Necroptosis; Nervous System Malformations; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded; Skin	2022
Enteric glial adenosine 2B receptor signaling mediates persistent epithelial barrier dysfunction following acute DSS colitis. Mucosal immunology, 2022, Volume: 15, Issue:5 Topics: Adenosine; Animals; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Inflammation; Intestinal Mucosa; Mice; Mice, Inbred C57BL; Neuroglia	2022
Extracellular Adenosine (eAdo) - A Stem cell reviews and reports, 2022, Volume: 18, Issue:8 Topics: Adenosine; Animals; Hematopoietic Stem Cells; Inflammasomes; Inflammation; Mice; NLR Family, Pyrin Domain-Containing 3 Protein	2022
RNA editing underlies genetic risk of common inflammatory diseases. Nature, 2022, Volume: 608, Issue:7923 Topics: Adenosine; Adenosine Deaminase; Alu Elements; Autoimmune Diseases; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Immune System Diseases; Immunity, Innate; Inflammation; Inosine; Interferon-Induced Helicase, IFIH1; Interferons; Quantitative Trait Loci; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded	2022
Empagliflozin inhibits macrophage inflammation through AMPK signaling pathway and plays an anti-atherosclerosis role. International journal of cardiology, 2022, 11-15, Volume: 367 Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Glucosides; Inflammation; Lipoproteins, LDL; Macrophages; Mice; NF-kappa B; Plaque, Atherosclerotic; RNA; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors	2022
Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model. International journal of molecular sciences, 2022, Oct-21, Volume: 23, Issue:20 Topics: Adenosine; Animals; Disease Models, Animal; Humans; Imiquimod; Inflammation; Methyltransferases; Mice; Psoriasis; RNA; RNA, Messenger	2022
Comprehensive Analysis and Functional Characteristics of Differential Expression of N6-Methyladenosine Methylation Modification in the Whole Transcriptome of Rheumatoid Arthritis. Mediators of inflammation, 2022, Volume: 2022 Topics: Adenosine; Animals; Arthritis, Rheumatoid; Inflammation; Methylation; Phosphatidylinositol 3-Kinases; RNA, Messenger; Transcriptome	2022
Adenosine A International journal of molecular sciences, 2022, Nov-01, Volume: 23, Issue:21 Topics: Adenosine; Animals; Bleomycin; Fibroblasts; Fibrosis; Inflammation; Lung; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Receptors, Purinergic P1; Transforming Growth Factor beta	2022
Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis. The Laryngoscope, 2023, Volume: 133, Issue:9 Topics: Adenosine; Animals; Disease Models, Animal; Inflammation; Mice; Mucins; Mucus; Sinusitis	2023
N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease. Frontiers in immunology, 2023, Volume: 14 Topics: Adenosine; Animals; Inflammation; Lung; Mice; Pulmonary Disease, Chronic Obstructive; RNA; RNA, Messenger	2023
dECM based dusal-responsive vascular graft with enzyme-controlled adenine release for long-term patency. International journal of biological macromolecules, 2023, Jul-01, Volume: 242, Issue:Pt 1 Topics: Adenosine; Blood Vessel Prosthesis; Humans; Inflammation; Macrophages	2023
Aspirin ameliorates atherosclerotic immuno-inflammation through regulating the Treg/Th17 axis and CD39-CD73 adenosine signaling via remodeling the gut microbiota in ApoE International immunopharmacology, 2023, Volume: 120 Topics: Adenosine; Animals; Apolipoproteins E; Aspirin; Atherosclerosis; Gastrointestinal Microbiome; Inflammation; Mice; Signal Transduction; T-Lymphocytes, Regulatory; Th17 Cells	2023
Metabolic reprogramming through mitochondrial biogenesis drives adenosine anti-inflammatory effects: new mechanism controlling gingival fibroblast hyper-inflammatory state. Frontiers in immunology, 2023, Volume: 14 Topics: Adenosine; AMP-Activated Protein Kinases; Anti-Inflammatory Agents; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Fibroblasts; Humans; Inflammation; Organelle Biogenesis; Sirtuin 1	2023
IF1 ablation prevents ATP synthase oligomerization, enhances mitochondrial ATP turnover and promotes an adenosine-mediated pro-inflammatory phenotype. Cell death & disease, 2023, 07-12, Volume: 14, Issue:7 Topics: Adenosine; Adenosine Triphosphate; Animals; ATPase Inhibitory Protein; Cell Differentiation; Humans; Inflammation; Mice; Mice, Knockout; Mitochondrial Proteins; Mitochondrial Proton-Translocating ATPases	2023
Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5'-monophosphate-activated protein kinase pathway and reshaping gut microbiota. Journal of the science of food and agriculture, 2023, Volume: 103, Issue:15 Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Diet, High-Fat; Fibrosis; Gastrointestinal Microbiome; Inflammation; Lipid Metabolism; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Polysaccharides	2023
CD73 inhibits titanium particle-associated aseptic loosening by alternating activation of macrophages. International immunopharmacology, 2023, Volume: 122 Topics: 5'-Nucleotidase; Adenosine; Humans; Inflammation; Macrophages; Osteolysis; Titanium	2023
Abnormal adenosine metabolism of neutrophils inhibits airway inflammation and remodeling in asthma model induced by Aspergillus fumigatus. BMC pulmonary medicine, 2023, Jul-14, Volume: 23, Issue:1 Topics: Adenosine; Airway Remodeling; Animals; Aspergillus fumigatus; Asthma; Bronchoalveolar Lavage Fluid; Chemokines; Cytokines; Inflammation; Mice; Neutrophils; Plant Extracts	2023
Liver fibrotic development is reduced through inflammation prevention by an adenosine derivative compound. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 165 Topics: Adenosine; Animals; Carbon Tetrachloride; Cytokines; Fibrosis; Inflammation; Liver; Liver Cirrhosis; Male; Rats; Rats, Wistar	2023
Association between ankylosing spondylitis and m6A methylation. Journal of orthopaedic surgery and research, 2023, Oct-07, Volume: 18, Issue:1 Topics: Adenosine; Gene Ontology; Humans; Inflammation; Methylation; Spondylitis, Ankylosing	2023
CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice. Scientific reports, 2023, 10-10, Volume: 13, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Angiotensin II; Animals; Female; Inflammation; Male; Mice; Mice, Knockout	2023
Assessing the gene expression of the adenosine 5'-monophosphate-activated protein kinase (AMPK) and its relation with the IL-6 and IL-10 plasma levels in COVID-19 patients. Molecular biology reports, 2023, Volume: 50, Issue:12 Topics: Adenosine; Adenosine Monophosphate; AMP-Activated Protein Kinases; COVID-19; Cytokines; Gene Expression; Humans; Inflammation; Interleukin-10; Interleukin-6; RNA, Messenger; SARS-CoV-2	2023
Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down-regulating the nuclear factor-kappa B signaling. Journal of digestive diseases, 2020, Volume: 21, Issue:1 Topics: Adenosine; Colitis, Ulcerative; Colon; Cytokines; Down-Regulation; Humans; Inflammation; Interleukin-1beta; Intestinal Mucosa; NF-kappa B; Peptide Fragments; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Signal Transduction; Tumor Necrosis Factor-alpha; Up-Regulation	2020
YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma. Molecular cancer, 2019, 11-18, Volume: 18, Issue:1 Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Epigenesis, Genetic; Humans; Inflammation; Liver Neoplasms; Methylation; Mice; Models, Biological; Neovascularization, Pathologic; RNA-Binding Proteins; RNA, Messenger; Transcriptome	2019
Deletion of equilibrative nucleoside transporter-2 protects against lipopolysaccharide-induced neuroinflammation and blood-brain barrier dysfunction in mice. Brain, behavior, and immunity, 2020, Volume: 84 Topics: Adenosine; Animals; Blood-Brain Barrier; Equilibrative Nucleoside Transporter 1; Equilibrative-Nucleoside Transporter 2; Gene Deletion; Inflammation; Lipopolysaccharides; Male; Mice; Neuroimmunomodulation	2020
GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation. Cellular & molecular biology letters, 2020, Volume: 25 Topics: Adenosine; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromogranins; Disease Progression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; GTP-Binding Protein alpha Subunits, Gs; Humans; Inflammation; Interleukin-6; Lipopolysaccharides; Liver Neoplasms; Methylation; Mice; Mice, Inbred BALB C; Mice, Nude; Mutation; RNA Interference; RNA, Long Noncoding; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2020
Purinergic signaling, DAMPs, and inflammation. American journal of physiology. Cell physiology, 2020, 05-01, Volume: 318, Issue:5 Topics: Adenosine; Adenosine Triphosphatases; Adenosine Triphosphate; Alarmins; Animals; Cell Membrane; Humans; Immunosuppressive Agents; Inflammation; Receptors, Purinergic P1; Receptors, Purinergic P2; Signal Transduction	2020
Targeting adenosine in SSc. Nature reviews. Rheumatology, 2020, Volume: 16, Issue:6 Topics: Adenosine; Adenosine Deaminase; Fibrosis; Humans; Inflammation; Scleroderma, Systemic; Vascular Diseases	2020
Disruption of hepatic one-carbon metabolism impairs mitochondrial function and enhances macrophage activity in methionine-choline-deficient mice. The Journal of nutritional biochemistry, 2020, Volume: 81 Topics: Adenosine; Animals; Carbon; Choline; Choline Deficiency; Diet; Disease Models, Animal; Fatty Liver; Flavins; Guanidine; Inflammation; Liver; Macrophages; Male; Methionine; Mice; Mice, Inbred C57BL; Mitochondria; Nucleotides; Purinergic P1 Receptor Antagonists; Thymidine	2020
7-Deaza-7-fluoro-2'-C-methyladenosine inhibits Zika virus infection and viral-induced neuroinflammation. Antiviral research, 2020, Volume: 180 Topics: Adenosine; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Chlorocebus aethiops; Culicidae; Humans; Inflammation; Mice; Nervous System Diseases; Neural Stem Cells; Vero Cells; Viral Load; Virus Replication; Zika Virus; Zika Virus Infection	2020
Adenosine Receptors as Neuroinflammation Modulators: Role of A Cells, 2020, 07-21, Volume: 9, Issue:7 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Cells, Cultured; Inflammation; Male; Neuroglia; Neurons; Rats, Wistar; Receptors, Purinergic P1; Triazines; Triazoles	2020
METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications. Theranostics, 2020, Volume: 10, Issue:20 Topics: Adenosine; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Forkhead Box Protein O1; HEK293 Cells; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Promoter Regions, Genetic; RNA, Messenger; THP-1 Cells; Transcription, Genetic	2020
Zbtb7b suppresses aseptic inflammation by regulating m Biochemical and biophysical research communications, 2020, 09-10, Volume: 530, Issue:1 Topics: Adenosine; Cell Line; DNA-Binding Proteins; Epigenesis, Genetic; Epithelial Cells; Gene Silencing; HEK293 Cells; Humans; Inflammation; Interleukin-6; RNA, Messenger; Transcription Factors	2020
Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses. Journal of immunology (Baltimore, Md. : 1950), 2020, 11-15, Volume: 205, Issue:10 Topics: Adenosine; Alu Elements; Datasets as Topic; DEAD Box Protein 58; HEK293 Cells; Humans; Inflammation; Inosine; Interferons; Multiple Sclerosis, Relapsing-Remitting; NF-kappa B; Receptors, Immunologic; RNA Editing; RNA-Seq; RNA, Double-Stranded; Signal Transduction; THP-1 Cells; Toll-Like Receptor 3; Transcriptional Activation; Whole Genome Sequencing	2020
The mRNA m6A reader YTHDF2 suppresses proinflammatory pathways and sustains hematopoietic stem cell function. The Journal of experimental medicine, 2021, 03-01, Volume: 218, Issue:3 Topics: Adenosine; Animals; Cell Lineage; Cell Proliferation; Cellular Senescence; Gene Deletion; Hematopoiesis; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Inflammation; Lymphocytes; Mice, Inbred C57BL; Myeloid Cells; RNA-Binding Proteins; RNA, Messenger	2021
Antinociceptive and neurochemical effects of a single dose of IB-MECA in chronic pain rat models. Purinergic signalling, 2020, Volume: 16, Issue:4 Topics: Adenosine; Analgesics; Animals; Chronic Pain; Disease Models, Animal; Inflammation; Male; Neuralgia; Rats; Rats, Wistar	2020
DZNep attenuates allergic airway inflammation in an ovalbumin-induced murine model. Molecular immunology, 2021, Volume: 131 Topics: Adenosine; Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Disease Models, Animal; Female; Hypersensitivity; Inflammation; Lung; Mice; Mice, Inbred BALB C; Ovalbumin	2021
Systematic deletion of adenosine receptors reveals novel roles in inflammation and pyroptosis in THP-1 macrophages. Molecular immunology, 2021, Volume: 132 Topics: Adenosine; Cells, Cultured; Cytokines; Gene Knockdown Techniques; Humans; Inflammation; Interleukin-10; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Macrophages; Pyroptosis; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Small Interfering; Signal Transduction	2021
Resveratrol Supplementation Attenuates Cognitive and Molecular Alterations under Maternal High-Fat Diet Intake: Epigenetic Inheritance over Generations. International journal of molecular sciences, 2021, Feb-01, Volume: 22, Issue:3 Topics: Adenosine; Animals; Body Weight; Brain; Cognition; Diet, High-Fat; Dietary Supplements; DNA Methylation; Epigenesis, Genetic; Epigenomics; Female; Inflammation; Leptin; Male; Maternal Exposure; Maze Learning; Methylation; Mice; Neurodegenerative Diseases; Neuronal Plasticity; Obesity; Pregnancy; Pregnancy, Animal; Prenatal Exposure Delayed Effects; Resveratrol; Triglycerides	2021
Acute moderate-intensity aerobic exercise promotes purinergic and inflammatory responses in sedentary, overweight and physically active subjects. Experimental physiology, 2021, Volume: 106, Issue:4 Topics: Adenosine; Exercise; Exercise Test; Humans; Inflammation; Male; Overweight	2021
Electrophysiological signatures of acute systemic lipopolysaccharide-induced inflammation: potential implications for delirium science. British journal of anaesthesia, 2021, Volume: 126, Issue:5 Topics: Adenosine; Age Factors; Animals; Caffeine; Cerebral Cortex; Cytokines; Delirium; Disease Models, Animal; Electroencephalography; Electrophysiological Phenomena; Humans; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Piroxicam; Prostaglandins; Wakefulness	2021
LJ529 attenuates mast cell-related inflammation via A Experimental neurology, 2021, Volume: 340 Topics: Adenosine; Adenosine A3 Receptor Agonists; Aldehyde Dehydrogenase, Mitochondrial; Animals; Dose-Response Relationship, Drug; Inflammation; Male; Mast Cells; Protein Kinase C-epsilon; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A3; Signal Transduction; Subarachnoid Hemorrhage; Thionucleosides	2021
Testicular adenosine acts as a pro-inflammatory molecule: role of testicular peritubular cells. Molecular human reproduction, 2021, 07-01, Volume: 27, Issue:7 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Adenosine-5'-(N-ethylcarboxamide); Adult; Aminopyridines; Animals; Apyrase; Cells, Cultured; Cytokines; GPI-Linked Proteins; Humans; Infertility, Male; Inflammation; Male; Mice; Mice, Inbred C57BL; Middle Aged; Receptor, Adenosine A2B; Receptors, Purinergic P1; RNA Interference; RNA, Small Interfering; Testis	2021
Targeting the Hypoxia-Adenosine Link for Controlling Excessive Inflammation. Anesthesiology, 2021, 07-01, Volume: 135, Issue:1 Topics: Adenosine; Humans; Hypoxia; Inflammation	2021
Impact of Adenosine Analogue, Adenosine-5'-N-Ethyluronamide (NECA), on Insulin Signaling in Skeletal Muscle Cells. BioMed research international, 2021, Volume: 2021 Topics: Acetyl-CoA Carboxylase; Acyl-CoA Dehydrogenase, Long-Chain; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Carnitine O-Palmitoyltransferase; Hexokinase; Inflammation; Insulin; Interleukin-6; Muscle Fibers, Skeletal; Muscle, Skeletal; Myoblasts; Nuclear Receptor Subfamily 4, Group A, Member 1; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phosphofructokinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Rats; Receptors, Cytoplasmic and Nuclear; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factors	2021
Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats. Biomolecules, 2021, 07-19, Volume: 11, Issue:7 Topics: Adenosine; Allografts; Allopurinol; Animals; Caspases; Creatinine; Cytokines; Diamines; Free Radical Scavengers; Glutathione; Inflammation; Insulin; Kidney; Kidney Transplantation; Male; Mitochondria; Organ Preservation Solutions; Raffinose; Rats, Inbred BN; Rats, Inbred Lew; Sulfhydryl Compounds	2021
Adenosine Formed by CD73 on T Cells Inhibits Cardiac Inflammation and Fibrosis and Preserves Contractile Function in Transverse Aortic Constriction-Induced Heart Failure. Circulation. Heart failure, 2017, Volume: 10, Issue:4 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Aorta; Collagen; Constriction; Disease Models, Animal; Fibrosis; Heart Failure; Inflammation; Interleukin-3; Male; Mice; Mice, Knockout; Signal Transduction; T-Lymphocytes	2017
MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. Cancer research, 2017, 09-01, Volume: 77, Issue:17 Topics: 5'-Nucleotidase; Adenosine; Adoptive Transfer; Animals; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Immunotherapy; Inflammation; Melanoma; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Neoplasm Invasiveness; Prognosis; Retrospective Studies; T-Lymphocytes; Transcription Factor AP-1; Tumor Cells, Cultured	2017
Occurrence of oxidative stress in dairy cows seropositives for Brucella abortus. Microbial pathogenesis, 2017, Volume: 110 Topics: Adenosine; Animals; Antibodies, Bacterial; Biomarkers; Brazil; Brucella abortus; Brucellosis, Bovine; Catalase; Cattle; Cattle Diseases; Female; Inflammation; Oxidative Stress; Pregnancy; Seroepidemiologic Studies; Serologic Tests; Superoxide Dismutase	2017
Immune-inflammatory activation after a single laparotomy in a rat model: effect of adenosine, lidocaine and Mg Innate immunity, 2017, Volume: 23, Issue:5 Topics: Adenosine; Alkalosis, Respiratory; Animals; Blood Coagulation; Blood Platelets; Complex Mixtures; Disease Models, Animal; Fibrinolysis; Humans; Immunity, Innate; Inflammation; Infusions, Intravenous; Interleukin-10; Interleukin-6; Laparotomy; Lidocaine; Magnesium; Male; Neutrophils; Postoperative Complications; Rats; Rats, Sprague-Dawley	2017
Relevance of proteolysis and proteasome activation in fatty liver graft preservation: An Institut Georges Lopez-1 World journal of gastroenterology, 2017, Jun-21, Volume: 23, Issue:23 Topics: Adenosine; Allopurinol; Animals; Apoptosis; Autophagy; Chromatography, High Pressure Liquid; Chymotrypsin; Fatty Liver; Glutathione; Graft Survival; Homozygote; Inflammation; Insulin; Liver; Liver Transplantation; Male; Mitochondria; Organ Preservation; Organ Preservation Solutions; Perfusion; Proteasome Endopeptidase Complex; Proteolysis; Raffinose; Rats; Rats, Zucker	2017
Intestinal Epithelial Ecto-5'-Nucleotidase (CD73) Regulates Intestinal Colonization and Infection by Nontyphoidal Salmonella. Infection and immunity, 2017, Volume: 85, Issue:10 Topics: 5'-Nucleotidase; Adenosine; Animals; Bacterial Load; Cell Line; Epithelial Cells; Host-Pathogen Interactions; Inflammation; Intestinal Mucosa; Mice; Mice, Knockout; Nucleotidases; Salmonella enterica; Salmonella typhimurium; Signal Transduction	2017
More Evidence for Non-P2Y JACC. Cardiovascular interventions, 2017, 08-28, Volume: 10, Issue:16 Topics: Acute Coronary Syndrome; Adenosine; Cross-Over Studies; Diabetes Mellitus; Endothelial Progenitor Cells; Humans; Inflammation; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Ticagrelor	2017
Treatment with A Cell death & disease, 2017, 10-05, Volume: 8, Issue:10 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Humans; Inflammation; Ischemia; Male; Microglia; Nitrobenzenes; Pyridines; Rats; Receptor, Adenosine A2A; Reperfusion Injury; Retina; Retinal Diseases	2017
Regulation of endothelial intracellular adenosine via adenosine kinase epigenetically modulates vascular inflammation. Nature communications, 2017, 10-16, Volume: 8, Issue:1 Topics: Adenosine; Adenosine Kinase; Adenosylhomocysteinase; Animals; Atherosclerosis; Blood Vessels; Cerebral Cortex; Endothelial Cells; Epigenesis, Genetic; Gene Expression Regulation; Gene Knockdown Techniques; Inflammation; Mice; Mice, Knockout, ApoE; Reperfusion Injury	2017
Extracellular adenosine produced by ecto-5'-nucleotidase (CD73) regulates macrophage pro-inflammatory responses, nitric oxide production, and favors Salmonella persistence. Nitric oxide : biology and chemistry, 2018, 01-30, Volume: 72 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cytokines; Host-Pathogen Interactions; Inflammation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; RAW 264.7 Cells; Salmonella Infections; Salmonella typhimurium	2018
Electroacupuncture Attenuates Induction of Inflammatory Pain by Regulating Opioid and Adenosine Pathways in Mice. Scientific reports, 2017, Nov-15, Volume: 7, Issue:1 Topics: Adenosine; Analgesics, Opioid; Animals; Astrocytes; Cyclooxygenase 2; Disease Models, Animal; Electroacupuncture; Ganglia, Spinal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Hyperalgesia; Inflammation; Mice; NF-kappa B; Pain; Pain Management; Protein Kinase C-epsilon; Rats; Receptor for Advanced Glycation End Products; S100 Calcium Binding Protein beta Subunit; Signal Transduction; Spinal Cord Dorsal Horn	2017
Adenosine, lidocaine and Mg2+ (ALM) fluid therapy attenuates systemic inflammation, platelet dysfunction and coagulopathy after non-compressible truncal hemorrhage. PloS one, 2017, Volume: 12, Issue:11 Topics: Adenosine; Animals; Blood Coagulation Disorders; Blood Platelet Disorders; Cytokines; Fluid Therapy; Hematologic Tests; Hemorrhage; Inflammation; Lidocaine; Magnesium; Male; Rats; Rats, Sprague-Dawley	2017
Adenosine A The Journal of pharmacology and experimental therapeutics, 2018, Volume: 364, Issue:2 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Carrageenan; Cytokines; Edema; Fibroblast Growth Factor 2; Gene Expression Regulation; Hindlimb; Inflammation; Male; Phenethylamines; Rats; Rats, Wistar; Receptor, Adenosine A2A	2018
Identification of allosteric inhibitors of the ecto-5'-nucleotidase (CD73) targeting the dimer interface. PLoS computational biology, 2018, Volume: 14, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Allosteric Site; Antibodies, Monoclonal; Antineoplastic Agents; Cell Proliferation; Computational Biology; Crystallography, X-Ray; GPI-Linked Proteins; Humans; Immune System; Inflammation; Kinetics; Magnetic Resonance Spectroscopy; Models, Statistical; Molecular Dynamics Simulation; Phenotype; Protein Binding; Protein Conformation; Protein Multimerization; Recombinant Proteins; Software	2018
Purinergic signaling modulates the splenic inflammatory response in silver catfish naturally infected with Ichthyophthirius multifiliis. Parasitology research, 2018, Volume: 117, Issue:4 Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Animals; Catfishes; Ciliophora Infections; Hymenostomatida; Inflammation; Pyrophosphatases; Signal Transduction; Spleen	2018
Impaired Production and Diurnal Regulation of Vascular RvD Circulation research, 2018, 03-16, Volume: 122, Issue:6 Topics: Adenosine; Animals; Blood Platelets; Circadian Rhythm; Fatty Acids, Unsaturated; Humans; Inflammation; Leukocytes; Lipoxygenase; Mice; Myocardial Infarction; Thromboxane B2	2018
METTL3 regulates alternative splicing of MyD88 upon the lipopolysaccharide-induced inflammatory response in human dental pulp cells. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:5 Topics: Adenosine; Adolescent; Adult; Alternative Splicing; Cytokines; Dental Pulp; Down-Regulation; Humans; Inflammation; Inflammation Mediators; Lipopolysaccharides; MAP Kinase Signaling System; Methyltransferases; Myeloid Differentiation Factor 88; NF-kappa B; RNA, Messenger; Up-Regulation; Young Adult	2018
Extracellular Purine Metabolism Is the Switchboard of Immunosuppressive Macrophages and a Novel Target to Treat Diseases With Macrophage Imbalances. Frontiers in immunology, 2018, Volume: 9 Topics: Adenosine; Animals; Arthritis, Rheumatoid; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Inflammation; Macrophage Colony-Stimulating Factor; Macrophages; Male; Methotrexate; Mice; Monocytes; Purines; Synovial Fluid	2018
The promotion of tissue engineering blood vessel patency by CGS21680 through regulating pro-inflammatory activities of endothelial progenitor cell. Journal of biomedical materials research. Part A, 2018, Volume: 106, Issue:10 Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adenosine; Animals; Blood Vessel Prosthesis; Cell Count; Cell Movement; Computed Tomography Angiography; Delayed-Action Preparations; Endothelial Progenitor Cells; Inflammation; Lipopolysaccharides; Macrophages; Monocytes; Nanoparticles; Phenethylamines; Rats, Wistar; Tissue Engineering; Vascular Patency	2018
Ferulic Acid Protected from Kidney Ischemia Reperfusion Injury in Mice: Possible Mechanism Through Increasing Adenosine Generation via HIF-1α. Inflammation, 2018, Volume: 41, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apoptosis; Apyrase; Coumaric Acids; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Kidney; Mice; Protective Agents; Reperfusion Injury	2018
International journal of molecular sciences, 2018, Nov-07, Volume: 19, Issue:11 Topics: Adenosine; Animals; Anti-Inflammatory Agents; Cordyceps; Deoxyadenosines; Dermatitis, Contact; Down-Regulation; Fermentation; Flavonoids; I-kappa B Proteins; Inflammation; Inflammation Mediators; Interleukin-1beta; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Nitric Oxide; Nitric Oxide Synthase Type II; Pediococcus pentosaceus; Phosphorylation; Polyphenols; RAW 264.7 Cells; RNA, Messenger; Transcription Factor RelA; Tumor Necrosis Factor-alpha	2018
Mettl3 Deficiency Sustains Long-Chain Fatty Acid Absorption through Suppressing Traf6-Dependent Inflammation Response. Journal of immunology (Baltimore, Md. : 1950), 2019, 01-15, Volume: 202, Issue:2 Topics: Adenosine; Animals; Cell Line; Fatty Acids; Gene Silencing; Inflammation; Intestinal Absorption; Methylation; Methyltransferases; NF-kappa B; RNA, Messenger; Signal Transduction; Swine; TNF Receptor-Associated Factor 6	2019
Soluble and membrane-bound adenylate kinase and nucleotidases augment ATP-mediated inflammation in diabetic retinopathy eyes with vitreous hemorrhage. Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Adult; Aged; Alkaline Phosphatase; Diabetic Retinopathy; Eye; Female; Humans; Inflammation; Male; Middle Aged; Nucleotidases; Vitreous Hemorrhage	2019
Inhibition of LPS-stimulated ecto-adenosine deaminase attenuates endothelial cell activation. Journal of molecular and cellular cardiology, 2019, Volume: 128 Topics: Adenosine; Adenosine Deaminase; Animals; Aorta; Atherosclerosis; Cell Membrane; Cholesterol; Endothelial Cells; Exocytosis; Gene Expression Regulation; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Janus Kinases; Lipopolysaccharides; Metabolism; Mice; Pentostatin; Rats; STAT Transcription Factors; Vascular Cell Adhesion Molecule-1	2019
CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signalling. Brain : a journal of neurology, 2019, 03-01, Volume: 142, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Animals; Disease Models, Animal; Dopamine; Dopaminergic Neurons; GPI-Linked Proteins; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurodegenerative Diseases; Parkinson Disease; Receptor, Adenosine A2A; Signal Transduction	2019
Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation. BMC gastroenterology, 2019, Feb-08, Volume: 19, Issue:1 Topics: Adenosine; Allopurinol; Animals; Apoptosis; Cold Temperature; Glutathione; Hepatocytes; Hydrogen; Hydrogen-Ion Concentration; Inflammation; Insulin; Kidney; Liver Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Oxidative Stress; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury; RNA, Messenger	2019
The cordycepin derivative IMM-H007 improves endothelial dysfunction by suppressing vascular inflammation and promoting AMPK-dependent eNOS activation in high-fat diet-fed ApoE knockout mice. European journal of pharmacology, 2019, Jun-05, Volume: 852 Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Atherosclerosis; Blood Vessels; Diet, High-Fat; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Mice; Mice, Knockout, ApoE; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Proto-Oncogene Proteins c-akt; Tumor Necrosis Factor-alpha	2019
m6A Reader YTHDF2 Regulates LPS-Induced Inflammatory Response. International journal of molecular sciences, 2019, 03-15, Volume: 20, Issue:6 Topics: Adenosine; Animals; Cytokines; Gene Expression Regulation; Inflammation; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; MAP Kinase Kinase 4; Mice; Phosphorylation; Protein Serine-Threonine Kinases; RAW 264.7 Cells; RNA-Binding Proteins; Signal Transduction; Up-Regulation	2019
Adenosine A2a receptor agonist CGS21680 treatment attenuates cardiopulmonary bypass‑associated inflammatory lung injury in juvenile rats. Molecular medicine reports, 2019, Volume: 20, Issue:1 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cardiopulmonary Bypass; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Lung; Lung Injury; Peroxidase; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Tumor Necrosis Factor-alpha	2019
Lipotoxicity-associated inflammation is prevented by guarana ( Drug and chemical toxicology, 2021, Volume: 44, Issue:5 Topics: Adenosine; Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperlipidemias; Inflammation; Lymphocytes; Male; Rats; Rats, Wistar; Simvastatin; Theobromine; Theophylline	2021
A novel AMPK activator improves hepatic lipid metabolism and leukocyte trafficking in experimental hepatic steatosis. Journal of pharmacological sciences, 2019, Volume: 140, Issue:2 Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Cell Adhesion; Cell Movement; Disease Models, Animal; Enzyme Activators; Fatty Liver; Hep G2 Cells; Humans; Inflammation; Leukocytes; Lipid Metabolism; Liver; Male; Mesocricetus	2019
NETing the mechanism of inflammation in DADA2. Blood, 2019, 07-25, Volume: 134, Issue:4 Topics: Adenosine; Adenosine Deaminase; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Severe Combined Immunodeficiency	2019
Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2013, Volume: 27, Issue:6 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Aortic Aneurysm, Abdominal; CD4-Positive T-Lymphocytes; Cytokines; Humans; Inflammation; Male; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Mice, Knockout; Pancreatic Elastase; Phenethylamines; Phenotype; Receptors, Adenosine A2; Triazines; Triazoles	2013
Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC. Cardiovascular imaging, 2013, Volume: 6, Issue:6 Topics: Adenosine; Adult; Analysis of Variance; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Circulation; Electrocardiography; Female; Humans; Inflammation; Inflammation Mediators; Male; Microcirculation; Microvascular Angina; Microvessels; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Risk Factors; Up-Regulation; Vasodilator Agents	2013
Potential roles of adenosine deaminase-2 in diabetic retinopathy. Biochemical and biophysical research communications, 2013, Jul-05, Volume: 436, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Adenosine Deaminase; Animals; Cell Hypoxia; Diabetic Retinopathy; Enzyme Activation; Female; Glycated Serum Albumin; Glycation End Products, Advanced; GPI-Linked Proteins; Humans; Inflammation; Intercellular Signaling Peptides and Proteins; Microglia; Middle Aged; Receptors, Purinergic P1; Retina; RNA, Small Interfering; Serum Albumin; Signal Transduction; Swine; Tumor Necrosis Factor-alpha; U937 Cells	2013
Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine (CPA) and opioid receptors in spinal cord nociceptive reflexes. Life sciences, 2013, Aug-14, Volume: 93, Issue:5-6 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Inflammation; Male; Pain; Pain Measurement; Rats; Rats, Wistar; Receptor, Adenosine A1; Receptors, Opioid; Reflex; Spinal Cord	2013
Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 346, Issue:3 Topics: Adenosine; Adenosine A2 Receptor Agonists; Algorithms; Aminopyridines; Calcium; Cell Line; Cyclic AMP; Cyclic AMP Response Element Modulator; Cytosol; Dexamethasone; Epithelial Cells; Humans; Inflammation; Phenethylamines; Pulmonary Disease, Chronic Obstructive; Real-Time Polymerase Chain Reaction; Receptor, Adenosine A2B; Receptors, Glucocorticoid; Respiratory Mucosa; RNA, Messenger; Transfection	2013
Adenosine increases LPS-induced nuclear factor kappa B activation in smooth muscle cells via an intracellular mechanism and modulates it via actions on adenosine receptors. Acta physiologica (Oxford, England), 2014, Volume: 210, Issue:3 Topics: Adenosine; Animals; Cells, Cultured; Enzyme Activation; Immunohistochemistry; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; NF-kappa B; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P1; Reverse Transcriptase Polymerase Chain Reaction	2014
LPS-induced oxidative stress and inflammatory reaction in the rat striatum. Pharmacological reports : PR, 2013, Volume: 65, Issue:4 Topics: Adenosine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Glutamic Acid; Hydroxyl Radical; Inflammation; Injections, Intraperitoneal; Lipopolysaccharides; Microinjections; Nerve Degeneration; Neuroglia; Oxidative Stress	2013
A2B adenosine receptors prevent insulin resistance by inhibiting adipose tissue inflammation via maintaining alternative macrophage activation. Diabetes, 2014, Volume: 63, Issue:3 Topics: Adenosine; Adipose Tissue; Animals; CCAAT-Enhancer-Binding Protein-beta; Cells, Cultured; Cholesterol; Glucose; Homeostasis; Inflammation; Insulin Resistance; Macrophage Activation; Male; Mice; Mice, Inbred C57BL; PPAR gamma; Receptor, Adenosine A2B; Triglycerides	2014
Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. American journal of physiology. Lung cellular and molecular physiology, 2014, Mar-15, Volume: 306, Issue:6 Topics: Acute Lung Injury; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Count; Cytokines; Endothelial Cells; Endothelium; Inflammation; Interleukin-6; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; Respiratory Distress Syndrome; Tumor Necrosis Factor-alpha	2014
Adenosine regulates the proinflammatory signaling function of thrombin in endothelial cells. Journal of cellular physiology, 2014, Volume: 229, Issue:9 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Blood Coagulation; Capillary Permeability; Cell Adhesion; Cells, Cultured; Coculture Techniques; Cyclic AMP; Dose-Response Relationship, Drug; E-Selectin; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; NF-kappa B; Protein Transport; Receptor, Adenosine A2A; Receptor, Adenosine A2B; rhoA GTP-Binding Protein; RNA Interference; Signal Transduction; Thrombin; Transfection; Vascular Cell Adhesion Molecule-1	2014
A novel IKKα inhibitor, noraristeromycin, blocks the chronic inflammation associated with collagen-induced arthritis in mice. Modern rheumatology, 2014, Volume: 24, Issue:5 Topics: Adenosine; Administration, Oral; Animals; Anti-Inflammatory Agents; Arthritis, Experimental; Disease Progression; Drug Administration Schedule; I-kappa B Kinase; Inflammation; Mice	2014
Cyclodextrin curcumin formulation improves outcome in a preclinical pig model of marginal kidney transplantation. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2014, Volume: 14, Issue:5 Topics: Adenosine; Allopurinol; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Chemistry, Pharmaceutical; Curcumin; Cyclodextrins; Disease Models, Animal; Fibrosis; Flow Cytometry; Glutathione; Graft Rejection; Humans; Inflammation; Insulin; Kidney Transplantation; Kidney Tubules; Male; Organ Preservation Solutions; Oxidative Stress; Prostate; Raffinose; Real-Time Polymerase Chain Reaction; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Swine	2014
Activation of adenosine A3 receptor alleviates TNF-α-induced inflammation through inhibition of the NF-κB signaling pathway in human colonic epithelial cells. Mediators of inflammation, 2014, Volume: 2014 Topics: Adenosine; Colon; Epithelial Cells; HT29 Cells; Humans; Inflammation; Interleukin-1beta; Interleukin-8; NF-kappa B; Receptor, Adenosine A3; Signal Transduction; Tumor Necrosis Factor-alpha	2014
Topical application of the adenosine A2A receptor agonist CGS-21680 prevents phorbol-induced epidermal hyperplasia and inflammation in mice. Experimental dermatology, 2014, Volume: 23, Issue:8 Topics: Adenosine; Adenosine A2 Receptor Agonists; Administration, Topical; Animals; Anti-Inflammatory Agents; Cell Proliferation; Collagen; Cytokines; Dexamethasone; Disease Models, Animal; Epidermis; Female; Hyperplasia; Inflammation; Mice; Peroxidase; Phenethylamines; Skin Diseases; Tetradecanoylphorbol Acetate	2014
Acute hyperammonemia and systemic inflammation is associated with increased extracellular brain adenosine in rats: a biosensor study. Neurochemical research, 2015, Volume: 40, Issue:2 Topics: Adenosine; Animals; Biosensing Techniques; Brain; Extracellular Space; Hyperammonemia; Inflammation; Male; Rats; Rats, Wistar	2015
The volatile anesthetic isoflurane increases endothelial adenosine generation via microparticle ecto-5'-nucleotidase (CD73) release. PloS one, 2014, Volume: 9, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Amides; Anesthetics, Inhalation; Animals; Antigens, CD; Cadherins; Cell Line, Transformed; Cell-Derived Microparticles; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Isoflurane; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Myosin-Light-Chain Phosphatase; Pyridines; rho-Associated Kinases; Signal Transduction	2014
Targeting adenosine receptors to prevent inflammatory skin diseases. Experimental dermatology, 2014, Volume: 23, Issue:8 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Epidermis; Female; Inflammation; Phenethylamines; Skin Diseases	2014
Histomorphometric evaluation of ischemia-reperfusion injury and the effect of preservation solutions histidine-tryptophan-ketoglutarate and University of Wisconsin in limb transplantation. Transplantation, 2014, Oct-15, Volume: 98, Issue:7 Topics: Adenosine; Allopurinol; Animals; Cold Ischemia; Dose-Response Relationship, Drug; Extremities; Glucose; Glutathione; Inflammation; Insulin; Male; Mannitol; Microscopy, Confocal; Microscopy, Electron, Transmission; Muscle, Skeletal; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury; Sciatic Nerve; Time Factors	2014
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain. Journal of neuroscience research, 2015, Volume: 93, Issue:1 Topics: Adenosine; Animals; Benzoxazines; Disease Models, Animal; Edema; Freund's Adjuvant; Hyperalgesia; Immersion; Indoles; Inflammation; Male; Mice; Morpholines; Naloxone; Naphthalenes; Narcotic Antagonists; Neurobiology; Pain Measurement; Receptor, Adenosine A1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Water Purification	2015
Adenosine protects Sprague Dawley rats from high-fat diet and repeated acute restraint stress-induced intestinal inflammation and altered expression of nutrient transporters. Journal of animal physiology and animal nutrition, 2015, Volume: 99, Issue:2 Topics: Adenosine; Animal Feed; Animals; Carrier Proteins; Dietary Fats; Drinking Water; Gene Expression Regulation; Inflammation; Male; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Physiological	2015
Interaction of the adenosine A1 receptor agonist N6-cyclopentyladenosine and κ-opioid receptors in rat spinal cord nociceptive reflexes. Behavioural pharmacology, 2014, Volume: 25, Issue:8 Topics: Adenosine; Animals; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electric Stimulation; Fentanyl; Inflammation; Male; Naloxone; Naltrexone; Narcotic Antagonists; Pain; Pain Measurement; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reflex; Spinal Cord	2014
CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection. Infection and immunity, 2015, Volume: 83, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antineoplastic Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Inflammation; Inflammation Mediators; Interleukin-1beta; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Nitric Oxide; Purinergic P1 Receptor Agonists; Toxoplasma; Toxoplasmosis; Tumor Necrosis Factor-alpha	2015
Inhibition of adenosine kinase attenuates inflammation and neurotoxicity in traumatic optic neuropathy. Journal of neuroimmunology, 2014, Dec-15, Volume: 277, Issue:1-2 Topics: Adenosine; Adenosine Kinase; Animals; Anti-Inflammatory Agents; Calcium-Binding Proteins; Cells, Cultured; Disease Models, Animal; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Imidazoles; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Morpholines; Neurotoxicity Syndromes; Nitric Oxide Synthase Type I; Optic Nerve Injuries; Oxidative Stress; Pyridines; Pyrimidines; Retina	2014
Adenosine A2A receptor, a potential valuable target for controlling reoxygenated DCs-triggered inflammation. Molecular immunology, 2015, Volume: 63, Issue:2 Topics: Adenosine; Animals; Cell Differentiation; Cytokines; Dendritic Cells; Female; Inflammation; Inflammation Mediators; Mice, Inbred C57BL; Models, Biological; Molecular Targeted Therapy; Oxygen; Phenethylamines; Phenotype; Receptor, Adenosine A2A; RNA, Messenger; Signal Transduction; Up-Regulation	2015
Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease. Journal of medicinal chemistry, 2015, Jan-08, Volume: 58, Issue:1 Topics: Adenosine; Animals; Autoimmune Diseases; Cells, Cultured; Class I Phosphatidylinositol 3-Kinases; Crystallography, X-Ray; Disease Models, Animal; Drug Discovery; Female; Humans; Inflammation; Mice, Inbred BALB C; Mice, Transgenic; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Quinolines; Rats, Inbred Lew; Sf9 Cells; Structure-Activity Relationship	2015
Expression of CD73 and A2A receptors in cells from subjects with obesity and type 2 diabetes mellitus. Immunobiology, 2015, Volume: 220, Issue:8 Topics: 5'-Nucleotidase; Adenosine; Adult; Antigens, CD; Apoptosis; Apyrase; Body Mass Index; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 2; Gene Expression Regulation; GPI-Linked Proteins; Humans; Inflammation; Lymphocyte Subsets; Lymphocytes; Obesity; Phenethylamines; Receptor, Adenosine A2A; Triazines; Triazoles	2015
MicroRNA-146b-3p regulates retinal inflammation by suppressing adenosine deaminase-2 in diabetes. BioMed research international, 2015, Volume: 2015 Topics: Adaptor Proteins, Signal Transducing; Adenosine; Aged; Animals; Autopsy; Diabetic Retinopathy; DNA-Binding Proteins; Female; Gene Expression Regulation, Enzymologic; Humans; Inflammation; Male; Mice; MicroRNAs; Middle Aged; Retina; Swine; Transcription Factors; Tumor Necrosis Factor-alpha	2015
Adenosine A2 a receptor stimulation prevents proteinuria in diabetic rats by promoting an anti-inflammatory phenotype without affecting oxidative stress. Acta physiologica (Oxford, England), 2015, Volume: 214, Issue:3 Topics: Adenosine; Animals; Cytokines; Diabetic Nephropathies; Immunologic Factors; Inflammation; Male; Oxidative Stress; Proteinuria; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A	2015
Adenosine Modulates NR4A Orphan Nuclear Receptors To Attenuate Hyperinflammatory Responses in Monocytic Cells. Journal of immunology (Baltimore, Md. : 1950), 2015, Aug-15, Volume: 195, Issue:4 Topics: Adenosine; Animals; Cell Line; Chemokine CCL20; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hypersensitivity; Inflammation; Interleukin-23 Subunit p19; Macrophages; Mice; Models, Biological; Monocytes; NF-kappa B; Nuclear Receptor Subfamily 4, Group A, Member 1; Nuclear Receptor Subfamily 4, Group A, Member 2; Nuclear Receptor Subfamily 4, Group A, Member 3; Orphan Nuclear Receptors; Receptor, Adenosine A2A	2015
Pancreatic L-Glutamine Administration Protects Pig Islets From Cold Ischemic Injury and Increases Resistance Toward Inflammatory Mediators. Cell transplantation, 2016, Volume: 25, Issue:3 Topics: Adenosine; Allopurinol; Animals; Cold Ischemia; Female; Glutamine; Glutathione; Inflammation; Inflammation Mediators; Insulin; Islets of Langerhans; Islets of Langerhans Transplantation; Mice, Nude; Organ Preservation; Organ Preservation Solutions; Protective Agents; Raffinose; Reactive Oxygen Species; Swine	2016
CD73 Activity is Dispensable for the Polarization of M2 Macrophages. PloS one, 2015, Volume: 10, Issue:8 Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Cytokines; Flow Cytometry; GPI-Linked Proteins; Humans; Immunosuppressive Agents; Inflammation; Interferon-gamma; Interleukin-4; Lipopolysaccharides; Macrophage Colony-Stimulating Factor; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; Monocytes; Phenotype	2015
Effects of the 34C>T Variant of the AMPD1 Gene on Immune Function, Multi-Organ Dysfunction, and Mortality in Sepsis Patients. Shock (Augusta, Ga.), 2015, Volume: 44, Issue:6 Topics: Adenosine; Aged; AMP Deaminase; Community-Acquired Infections; Critical Care; Cytokines; Female; Genotype; Humans; Immune System; Immunity, Innate; Immunosuppression Therapy; Infections; Inflammation; Male; Middle Aged; Monocytes; Multiple Organ Failure; Pneumonia; Pneumonia, Ventilator-Associated; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prospective Studies; Sepsis	2015
Nephroprotective role of dipyridamole in diabetic nephropathy: Effect on inflammation and apoptosis. Life sciences, 2015, Dec-15, Volume: 143 Topics: Adenosine; Animals; Apoptosis; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dipyridamole; Humans; Inflammation; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome	2015
[Effect of WS070117M1 on chronic obstructive pulmonary disease in mice and the underling mechanisms of anti-inflammation]. Yao xue xue bao = Acta pharmaceutica Sinica, 2015, Volume: 50, Issue:8 Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Bronchoalveolar Lavage Fluid; Cell Line, Tumor; Disease Models, Animal; Humans; Inflammation; Interleukin-1beta; Interleukin-6; Interleukin-8; Leukocyte Count; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Neutrophils; Nicotiana; Pulmonary Disease, Chronic Obstructive; Smoke; Transforming Growth Factor beta1	2015
Multiple Ways of Targeting the Adenosine/Adenosine Receptor Axis in Lung Inflammation and Injury. Critical care medicine, 2016, Volume: 44, Issue:4 Topics: Adenosine; Humans; Inflammation; Lung; Pneumonia; Receptors, Purinergic P1	2016
Role of inflammatory cells and adenosine in lung ischemia reoxygenation injury using a model of lung donation after cardiac death. Experimental lung research, 2016, Volume: 42, Issue:3 Topics: Adenosine; Alveolar Epithelial Cells; Animals; Death; Inflammation; Interleukin-2; Lung; Lung Injury; Lung Transplantation; Lymphocytes; Male; Necrosis; Rats; Rats, Wistar; Reperfusion Injury; Tumor Necrosis Factor-alpha	2016
Sustained Elevated Adenosine via ADORA2B Promotes Chronic Pain through Neuro-immune Interaction. Cell reports, 2016, 06-28, Volume: 16, Issue:1 Topics: Adenosine; Adenosine Deaminase; Anemia, Sickle Cell; Animals; Behavior, Animal; Chronic Pain; Disease Models, Animal; Ganglia, Spinal; Gene Expression Regulation; Inflammation; Interleukin-6; Mice, Knockout; Myeloid Cells; Nervous System; Nociceptors; Receptor, Adenosine A2B; Receptors, Interleukin-6; Reflex; Sensory Receptor Cells; Signal Transduction; Solubility; STAT3 Transcription Factor; TRPV Cation Channels; Up-Regulation	2016
Protein phosphatase 2A activation attenuates inflammation in murine models of acute lung injury. American journal of physiology. Lung cellular and molecular physiology, 2016, Nov-01, Volume: 311, Issue:5 Topics: Acute Lung Injury; Adenosine; Animals; Cell Line; Chemokines; Disease Models, Animal; Endotoxins; Enzyme Activation; Epithelial Cells; Inflammation; JNK Mitogen-Activated Protein Kinases; Macrophages, Alveolar; Mice, Inbred C57BL; Phosphorylation; Protein Phosphatase 2; Pseudomonas aeruginosa; Respiratory Distress Syndrome	2016
Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis. The European respiratory journal, 2016, Volume: 48, Issue:6 Topics: Adenosine; Australia; Biomarkers; Bronchiectasis; Bronchoalveolar Lavage Fluid; Child, Preschool; Cystic Fibrosis; Female; Humans; Infant; Inflammation; Linear Models; Lipid Metabolism; Lung; Lung Diseases; Male; Mass Spectrometry; Metabolomics; Multivariate Analysis; Neutrophils; Oxidative Stress; Prognosis	2016
Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. Translational research : the journal of laboratory and clinical medicine, 2017, Volume: 182 Topics: Adenosine; Animals; Disease Progression; Enzyme Activation; Hepatocytes; Inflammation; Lipids; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phenethylamines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, Adenosine A2A; Signal Transduction; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory	2017
The reno-vascular A2B adenosine receptor protects the kidney from ischemia. PLoS medicine, 2008, Jun-24, Volume: 5, Issue:6 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Aminopyridines; Animals; Blood Vessels; Cytoprotection; Extracellular Fluid; Female; Inflammation; Ischemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Receptor, Adenosine A2B; Signal Transduction; Xanthines	2008
Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Molecular pharmacology, 2008, Volume: 74, Issue:3 Topics: Adenosine; Animals; Bone Marrow Cells; Cell Separation; Chemotaxis; Furans; Gene Expression Regulation; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Peritonitis; Phenethylamines; Purines; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptor, Adenosine A3; RNA, Messenger; Superoxides	2008
Regulation of leukocyte migration across endothelial barriers by ECTO-5'-nucleotidase-generated adenosine. Nucleosides, nucleotides & nucleic acids, 2008, Volume: 27, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Animals; Central Nervous System; Chemotaxis, Leukocyte; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Inflammation; Leukocytes; Lymph Nodes; Lymphatic Vessels; Mice; T-Lymphocytes	2008
The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant-induced arthritis rats. Biochemical pharmacology, 2008, Aug-15, Volume: 76, Issue:4 Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Arthritis; Arthritis, Rheumatoid; Disease Models, Animal; Humans; Inflammation; NF-kappa B; Phosphatidylinositol 3-Kinases; Protein Kinases; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Synovial Membrane	2008
The adenosine a2a receptor inhibits matrix-induced inflammation in a novel fashion. American journal of respiratory cell and molecular biology, 2009, Volume: 40, Issue:3 Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Bleomycin; Cell Line; Gene Expression Regulation; Humans; Hyaluronic Acid; Inflammation; Interleukin-12; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Receptor, Adenosine A2A; Tumor Necrosis Factor-alpha	2009
The antinociceptive interaction of anandamide and adenosine at the spinal level. Pharmacology, biochemistry, and behavior, 2009, Volume: 91, Issue:3 Topics: Adenosine; Analgesics; Animals; Arachidonic Acids; Caffeine; Dose-Response Relationship, Drug; Drug Interactions; Endocannabinoids; Hot Temperature; Inflammation; Injections, Spinal; Male; Pain; Pain Measurement; Polyunsaturated Alkamides; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Reaction Time	2009
Adenosine and inflammation: CD39 and CD73 are critical mediators in LPS-induced PMN trafficking into the lungs. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2009, Volume: 23, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; Cell Movement; Gene Expression Regulation; Inflammation; Lipopolysaccharides; Lung Diseases; Male; Mice; Mice, Knockout; Neutrophils; Nucleotidases; Phosphorylation; Solubility; Transcription, Genetic	2009
Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. Journal of vascular surgery, 2009, Volume: 49, Issue:3 Topics: Adenosine; Adenosine Diphosphate; Animals; Aorta; Aortic Aneurysm, Abdominal; Blood Platelets; Disease Models, Animal; Disease Progression; Elastic Tissue; Guinea Pigs; Inflammation; Male; Matrix Metalloproteinase 9; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Platelet Aggregation; Platelet Aggregation Inhibitors; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred Lew; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Ticagrelor; Time Factors; Transplantation, Heterologous	2009
Adenosine and IFN-{alpha} synergistically increase IFN-gamma production of human NK cells. Journal of leukocyte biology, 2009, Volume: 85, Issue:3 Topics: Adenosine; Apoptosis; Cell Proliferation; Humans; Immunity; Inflammation; Interferon-alpha; Interferon-gamma; Killer Cells, Natural; Receptor, Adenosine A3	2009
Hypoxia-inducible factor-dependent repression of equilibrative nucleoside transporter 2 attenuates mucosal inflammation during intestinal hypoxia. Gastroenterology, 2009, Volume: 136, Issue:2 Topics: Adenosine; Animals; Caco-2 Cells; Cell Line, Tumor; Cells, Cultured; Colon; Disease Models, Animal; Equilibrative-Nucleoside Transporter 2; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation; Intestinal Mucosa; Mice; Mice, Inbred C57BL	2009
Adenosine receptors in COPD and asymptomatic smokers: effects of smoking cessation. Virchows Archiv : an international journal of pathology, 2009, Volume: 454, Issue:3 Topics: Adenosine; Adult; Bronchoscopy; Chromatography, High Pressure Liquid; Disease Progression; Female; Humans; Inflammation; Inflammation Mediators; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Receptors, Purinergic P1; Smoking; Smoking Cessation; Sputum	2009
Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate. Journal of immunology (Baltimore, Md. : 1950), 2009, Mar-01, Volume: 182, Issue:5 Topics: Acute Disease; Adenosine; Animals; Cells, Cultured; Cyclic AMP; Disease Models, Animal; Granulomatous Disease, Chronic; Humans; Inflammation; Inflammation Mediators; Leukopenia; Membrane Glycoproteins; Mice; Mice, Knockout; NADPH Oxidase 2; NADPH Oxidases; Peritonitis	2009
Adenosine signaling mediates SUMO-1 modification of IkappaBalpha during hypoxia and reoxygenation. The Journal of biological chemistry, 2009, May-15, Volume: 284, Issue:20 Topics: 5'-Nucleotidase; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Cell Hypoxia; Gene Knockdown Techniques; HeLa Cells; Humans; Hypoxia; I-kappa B Proteins; Inflammation; Interleukin-6; Lung; Mice; Mice, Mutant Strains; NF-kappa B; NF-KappaB Inhibitor alpha; Pneumonia; Proteasome Endopeptidase Complex; Protein Processing, Post-Translational; Purinergic P1 Receptor Agonists; Receptors, Purinergic P1; SUMO-1 Protein; Transcription, Genetic; Vasodilator Agents	2009
Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. European heart journal, 2009, Volume: 30, Issue:15 Topics: Adenosine; Adult; Arthritis, Rheumatoid; Case-Control Studies; Coronary Artery Disease; Coronary Circulation; Endothelium, Vascular; Female; Fractional Flow Reserve, Myocardial; Humans; Inflammation; Lupus Erythematosus, Systemic; Male; Microcirculation; Positron-Emission Tomography; Prospective Studies; Risk Assessment; Vasodilator Agents	2009
Fructose-1,6-bisphosphate reduces inflammatory pain-like behaviour in mice: role of adenosine acting on A1 receptors. British journal of pharmacology, 2009, Volume: 158, Issue:2 Topics: Adenosine; Analgesics; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Fructosediphosphates; Hyperalgesia; Inflammation; Male; Mice; Pain Measurement; Receptor, Adenosine A1	2009
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment. Arthritis and rheumatism, 2009, Volume: 60, Issue:10 Topics: Adenosine; Adenosine A3 Receptor Antagonists; Animals; Anti-Inflammatory Agents; Apoptosis; Cartilage, Articular; Disease Models, Animal; Inflammation; Iodoacetates; Male; NF-kappa B; Osteoarthritis; Rats; Rats, Wistar; Signal Transduction	2009
Ecto-5'-nucleotidase (CD73) inhibits nociception by hydrolyzing AMP to adenosine in nociceptive circuits. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2010, Feb-10, Volume: 30, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Cell Membrane; Ganglia, Spinal; Hydrolysis; Hyperalgesia; Inflammation; Male; Mice; Mice, Knockout; Nerve Endings; Nociceptors; Pain; Presynaptic Terminals; Receptor, Adenosine A1; Sciatic Nerve; Skin	2010
Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants. Transplantation, 2010, Feb-27, Volume: 89, Issue:4 Topics: Adenosine; Allopurinol; Animals; Cell Culture Techniques; Cell Division; Cell Survival; Fingolimod Hydrochloride; Flow Cytometry; Glutathione; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Insulin; Kidney Transplantation; Male; Organ Preservation Solutions; Propylene Glycols; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury; Sphingosine	2010
Airway hyperresponsiveness, peak flow variability and inflammatory markers in non-asthmatic subjects with respiratory infections. The clinical respiratory journal, 2007, Volume: 1, Issue:1 Topics: Adenosine; Adult; Aged; Air; Asthma; Biomarkers; Breath Tests; Bronchial Hyperreactivity; Bronchial Provocation Tests; Bronchoconstrictor Agents; Cold Temperature; Common Cold; Eosinophil Cationic Protein; Humans; Inflammation; Methacholine Chloride; Middle Aged; Nitric Oxide; Peak Expiratory Flow Rate; Respiratory Sounds; Young Adult	2007
Changes induced by formalin pain in central alpha1-adrenoceptor density are modulated by adenosine receptor agonists. Journal of neural transmission (Vienna, Austria : 1996), 2010, Volume: 117, Issue:5 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Analgesics; Animals; Autoradiography; Central Nervous System; Disease Models, Animal; Inflammation; Male; Mice; Nociceptors; Pain; Pain Measurement; Phenethylamines; Prazosin; Receptor, Adenosine A2A; Receptors, Adrenergic, alpha-1	2010
Conversion of Th17-type into Th2-type inflammation by acetyl salicylic acid via the adenosine and uric acid pathway in the lung. Allergy, 2010, Volume: 65, Issue:9 Topics: Adenosine; Allergens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Asthma; Disease Models, Animal; Humans; Inflammation; Lipopolysaccharides; Lung; Mice; Mice, Inbred C57BL; Th17 Cells; Th2 Cells; Uric Acid	2010
Involvement of A1 adenosine receptors in altered vascular responses and inflammation in an allergic mouse model of asthma. American journal of physiology. Heart and circulatory physiology, 2010, Volume: 299, Issue:1 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Administration, Inhalation; Aerosols; Ambrosia; Animals; Antigens, Plant; Aorta; Asthma; Blotting, Western; Bronchial Hyperreactivity; Bronchoconstriction; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-5; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Plethysmography, Whole Body; Polymerase Chain Reaction; Receptor, Adenosine A1; RNA, Messenger; Vasodilation	2010
Membrane polarity: a target for myocardial protection and reduced inflammation in adult and pediatric cardiothoracic surgery. The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:6 Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardioplegic Solutions; Cardiovascular Diseases; Child; Endothelium, Vascular; Heart Arrest, Induced; Humans; Hyperkalemia; Inflammation; Lidocaine; Membrane Potentials; Myocardium; Postoperative Complications; Potassium; Risk Factors	2010
Activation of adenosine A2A receptor attenuates inflammatory response in a rat model of small-for-size liver transplantation. Transplantation proceedings, 2010, Volume: 42, Issue:5 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Alanine Transaminase; Animals; Chemokine CXCL2; Cytokines; Enzyme-Linked Immunosorbent Assay; Inflammation; Intercellular Adhesion Molecule-1; Liver; Liver Transplantation; Male; NF-kappa B; Organ Size; Peroxidase; Phenethylamines; Phosphorylation; Rats; Rats, Inbred Lew; Receptor, Adenosine A2A; Triazines; Triazoles; Tumor Necrosis Factor-alpha	2010
Peripheral adenosine A2A receptors are involved in carrageenan-induced mechanical hyperalgesia in mice. Neuroscience, 2010, Oct-27, Volume: 170, Issue:3 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Carrageenan; Female; Ganglia, Spinal; Hyperalgesia; Inflammation; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Knockout; Pain; Pain Threshold; Phenethylamines; Receptor, Adenosine A2A; Sex Characteristics; Triazines; Triazoles	2010
Adenosine, inflammation pathways and therapeutic challenges. Joint bone spine, 2011, Volume: 78, Issue:1 Topics: Adenosine; Antirheumatic Agents; Arthritis, Rheumatoid; Humans; Inflammation; Signal Transduction; Spinal Cord Injuries	2011
Why change? The Journal of thoracic and cardiovascular surgery, 2010, Volume: 140, Issue:6 Topics: Adenosine; Adult; Anti-Arrhythmia Agents; Cardiac Surgical Procedures; Cardioplegic Solutions; Cardiovascular Diseases; Child; Endothelium, Vascular; Heart Arrest, Induced; Humans; Hyperkalemia; Inflammation; Lidocaine; Membrane Potentials; Myocardium; Postoperative Complications; Potassium; Risk Factors	2010
Adenosine 2A receptor is protective against renal injury in MRL/lpr mice. Lupus, 2011, Volume: 20, Issue:7 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blotting, Western; Disease Models, Animal; Disease Progression; Female; Gene Expression; Inflammation; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Phenethylamines; Receptor, Adenosine A2A; Reverse Transcriptase Polymerase Chain Reaction; RNA	2011
Oral methylthioadenosine administration attenuates fibrosis and chronic liver disease progression in Mdr2-/- mice. PloS one, 2010, Dec-29, Volume: 5, Issue:12 Topics: Adenosine; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; Cyclin D1; Cytokines; Disease Progression; Fibroblasts; Fibrosis; Inflammation; Liver; Liver Diseases; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-jun; Thionucleosides	2010
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects. Journal of neuroinflammation, 2011, Apr-12, Volume: 8 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Inflammation; Infusion Pumps, Implantable; JNK Mitogen-Activated Protein Kinases; Male; Mice; Motor Activity; Phenethylamines; Pyrimidines; Spinal Cord; Spinal Cord Injuries; Triazoles	2011
Comparison of bronchial hyperresponsiveness to methacholine and adenosine and airway inflammation markers in patients with suspected asthma. The Journal of asthma : official journal of the Association for the Care of Asthma, 2011, Volume: 48, Issue:4 Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Asthma; Biomarkers; Breath Tests; Bronchi; Bronchial Hyperreactivity; Bronchoconstrictor Agents; Eosinophils; Exhalation; Female; Humans; Inflammation; Leukocyte Count; Male; Methacholine Chloride; Middle Aged; Nitric Oxide; Sensitivity and Specificity; Sputum; Young Adult	2011
Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics? Expert opinion on investigational drugs, 2011, Volume: 20, Issue:6 Topics: Adenosine; Animals; Anti-Inflammatory Agents; Drug Design; Humans; Inflammation; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1	2011
Adenosine reduces cell surface expression of toll-like receptor 4 and inflammation in response to lipopolysaccharide and matrix products. Journal of cardiovascular translational research, 2011, Volume: 4, Issue:6 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adult; Aged; Case-Control Studies; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Down-Regulation; Female; Heparitin Sulfate; Humans; Hyaluronic Acid; Inflammation; Ligands; Lipopolysaccharides; Luxembourg; Macrophages; Male; Middle Aged; Myocardial Infarction; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Registries; RNA, Messenger; Time Factors; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha	2011
Involvement of adenosine A2A receptors in engulfment-dependent apoptotic cell suppression of inflammation. Journal of immunology (Baltimore, Md. : 1950), 2011, Jun-15, Volume: 186, Issue:12 Topics: Adenosine; Animals; Apoptosis; Inflammation; Macrophages; Mice; Mice, Knockout; Peritonitis; Phagocytosis; Receptor, Adenosine A2A	2011
Adenosine derived from Staphylococcus aureus-engulfed macrophages functions as a potent stimulant for the induction of inflammatory cytokines in mast cells. BMB reports, 2011, Volume: 44, Issue:5 Topics: Adenosine; Animals; Cell Line; Cytokines; Humans; Inflammation; Interleukin-6; Interleukin-8; Macrophages; Mast Cells; Mice; Mice, Inbred C57BL; Phagocytosis; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Staphylococcus aureus	2011
The effect of A(2A) adenosine receptor activation on C-C chemokine receptor 7 expression in human THP1 macrophages during inflammation. Inflammation, 2012, Volume: 35, Issue:2 Topics: Adenosine; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Cell Line; Cell Movement; Chemokine CCL21; Humans; Inflammation; Macrophages; Phenethylamines; Receptors, Adenosine A2; Receptors, CCR7; RNA, Messenger; Triazines; Triazoles	2012
A3 adenosine receptor agonist reduces brain ischemic injury and inhibits inflammatory cell migration in rats. The American journal of pathology, 2011, Volume: 179, Issue:4 Topics: Adenosine; Adenosine A3 Receptor Agonists; Animals; Brain Infarction; Brain Injuries; Brain Ischemia; Cell Movement; Chemokine CCL2; Glucose; Inflammation; Interleukin-1beta; Lipopolysaccharides; Male; Microglia; Monocytes; N-Methylaspartate; Protein Transport; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; rho GTP-Binding Proteins; Thionucleosides; Tumor Necrosis Factor-alpha	2011
Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:1 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Arginase; CCAAT-Enhancer-Binding Protein-beta; Cell Line; Cyclic AMP Response Element-Binding Protein; Extracellular Space; Inflammation; Interleukin-13; Interleukin-4; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2A; Receptor, Adenosine A2B; STAT6 Transcription Factor; Tissue Inhibitor of Metalloproteinase-1; Toll-Like Receptor 4; Vasodilator Agents	2012
IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors. PloS one, 2011, Volume: 6, Issue:9 Topics: Adenosine; Blood Banks; Cells, Cultured; Fetal Blood; Gene Expression Regulation; Hexosaminidases; Humans; Immunoglobulin E; Immunohistochemistry; Inflammation; Interleukin-4; Mast Cells; Models, Biological; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic P1; RNA, Small Interfering; Tryptases	2011
Carbon monoxide inhibits apoptosis during cold storage and protects kidney grafts donated after cardiac death. Transplant international : official journal of the European Society for Organ Transplantation, 2012, Volume: 25, Issue:1 Topics: Adenosine; Allopurinol; Animals; Apoptosis; Carbon Monoxide; Cold Temperature; Cytosol; Death; Glutathione; Humans; Inflammation; Insulin; Kidney; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Lew; Reperfusion Injury; RNA, Messenger; Treatment Outcome	2012
Emerging adenosine receptor agonists: an update. Expert opinion on emerging drugs, 2011, Volume: 16, Issue:4 Topics: Adenosine; Arrhythmias, Cardiac; Clinical Trials as Topic; Diabetes Mellitus; Drugs, Investigational; Humans; Inflammation; Molecular Structure; Pain; Purinergic P1 Receptor Agonists; Treatment Outcome	2011
Increased adenosine concentration in bronchoalveolar lavage fluid of horses with lower airway inflammation. Veterinary journal (London, England : 1997), 2012, Volume: 193, Issue:1 Topics: Adenosine; Animals; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Female; Horse Diseases; Horses; Inflammation; Lung Diseases, Obstructive; Male; Respiratory System	2012
The effect of adenosine on pro-inflammatory cytokine production by porcine T cells. Veterinary immunology and immunopathology, 2012, Jan-15, Volume: 145, Issue:1-2 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Concanavalin A; Dose-Response Relationship, Drug; Flow Cytometry; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-2; Quinazolines; Swine; T-Lymphocyte Subsets; T-Lymphocytes; Triazoles; Tumor Necrosis Factor-alpha	2012
Tissue-resident ecto-5' nucleotidase (CD73) regulates leukocyte trafficking in the ischemic brain. Journal of immunology (Baltimore, Md. : 1950), 2012, Mar-01, Volume: 188, Issue:5 Topics: 5'-Nucleotidase; Adenosine; Animals; Bone Marrow Transplantation; Brain Edema; Brain Ischemia; Cell Movement; Extracellular Fluid; Infarction, Middle Cerebral Artery; Inflammation; Leukocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction; Tissue Distribution	2012
Preventative oral methylthioadenosine is anti-inflammatory and reduces DSS-induced colitis in mice. American journal of physiology. Gastrointestinal and liver physiology, 2012, Volume: 303, Issue:1 Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Colitis; Dextran Sulfate; Diet; Gene Expression; Inflammation; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Microarray Analysis; Peroxidase; RNA, Messenger; Thionucleosides	2012
Exhaled breath condensate purines correlate with lung function in infants and preschoolers. Pediatric pulmonology, 2013, Volume: 48, Issue:2 Topics: Adenosine; Adenosine Monophosphate; Biomarkers; Breath Tests; Child, Preschool; Cough; Cystic Fibrosis; Female; Humans; Infant; Inflammation; Kartagener Syndrome; Lung Diseases; Male; Mass Spectrometry; Respiratory Function Tests	2013
Adenosine A2A receptor activation prevents wear particle-induced osteolysis. Science translational medicine, 2012, May-23, Volume: 4, Issue:135 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cells, Cultured; Female; Humans; Inflammation; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteolysis; Phenethylamines; Prosthesis Failure; Receptor, Adenosine A2A	2012
Adenosine A2A receptor and TNF-α regulate the circadian machinery of the human monocytic THP-1 cells. Inflammation, 2013, Volume: 36, Issue:1 Topics: Adenosine; ARNTL Transcription Factors; Arthritis, Rheumatoid; Cell Line; Circadian Clocks; Circadian Rhythm; CLOCK Proteins; Cryptochromes; Fatigue; Humans; Inflammation; Interleukin-1; Interleukin-10; Methotrexate; Monocytes; Period Circadian Proteins; Phenethylamines; Receptor, Adenosine A2A; RNA, Messenger; Tumor Necrosis Factor-alpha	2013
Enzyme-coupled assays for simultaneous detection of nanomolar ATP, ADP, AMP, adenosine, inosine and pyrophosphate concentrations in extracellular fluids. Biochimica et biophysica acta, 2012, Volume: 1823, Issue:10 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Cell Line, Tumor; Chromatography, Thin Layer; Diphosphates; Enzyme Assays; Extracellular Fluid; Fluorometry; Homeostasis; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Inosine; Luminescent Measurements; Lymphocytes; Neoplasm Metastasis; Nucleosides; Nucleotides; Pyrophosphatases	2012
Carbon monoxide releasing molecules inhibit cell death resulting from renal transplantation related stress. The Journal of urology, 2013, Volume: 190, Issue:2 Topics: Adenosine; Allopurinol; Animals; Apoptosis; Glutathione; Graft Survival; Inflammation; Insulin; Kidney Transplantation; Male; Organ Preservation; Organ Preservation Solutions; Organometallic Compounds; Oxidative Stress; Raffinose; Rats, Inbred Lew; Reperfusion Injury	2013
Effects of adenosine receptor antagonists on the in vivo LPS-induced inflammation model of Parkinson's disease. Neurotoxicity research, 2013, Volume: 24, Issue:1 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Caffeine; Corpus Striatum; Dopamine; Dopaminergic Neurons; Glutamic Acid; Hydroxyl Radical; Inflammation; Lipopolysaccharides; Male; Microinjections; Parkinson Disease; Purines; Rats; Receptor, Adenosine A2A	2013
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats. PloS one, 2013, Volume: 8, Issue:1 Topics: Adenosine; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Experimental; Arthritis, Rheumatoid; Disease Models, Animal; Humans; Inflammation; Longitudinal Studies; Lymphocytes; Male; Methotrexate; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Receptors, Purinergic P1; Rituximab; Tumor Necrosis Factor-alpha; Up-Regulation	2013
Targeting purinergic signaling for perioperative organ protection. Anesthesiology, 2013, Volume: 118, Issue:5 Topics: Adenosine; Adenosine Triphosphate; Anesthetics; Humans; Hypoxia; Inflammation; Postoperative Complications; Receptors, Purinergic; Receptors, Purinergic P1; Signal Transduction	2013
Astrocyte-derived adenosine modulates increased sleep pressure during inflammatory response. Glia, 2013, Volume: 61, Issue:5 Topics: Adenosine; Animals; Astrocytes; Electroencephalography; Inflammation; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Transgenic; Receptor, Adenosine A1; Sleep; SNARE Proteins	2013
Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2002, Volume: 51, Issue:12 Topics: Adenosine; Adenosine Deaminase; Adult; Calcium; Calcium Radioisotopes; Calcium Signaling; Cyclic AMP; Cytosol; Fluorescent Dyes; Fura-2; Humans; In Vitro Techniques; Inflammation; Inosine Triphosphate; Leukocyte Elastase; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidants; Spectrometry, Fluorescence; Superoxides	2002
Identification of A3 receptor- and mast cell-dependent and -independent components of adenosine-mediated airway responsiveness in mice. Journal of immunology (Baltimore, Md. : 1950), 2003, Jul-01, Volume: 171, Issue:1 Topics: Adenosine; Administration, Inhalation; Aerosols; Animals; Bronchial Hyperreactivity; Cell Degranulation; Down-Regulation; Inflammation; Lung; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Neutrophil Infiltration; Receptor, Adenosine A3; Receptors, Purinergic P1; Up-Regulation	2003
IL-13 and adenosine: partners in a molecular dance? The Journal of clinical investigation, 2003, Volume: 112, Issue:3 Topics: Adenosine; Animals; Asthma; Humans; Inflammation; Interleukin-13; Lung Injury; Mice; Models, Biological; Signal Transduction; T-Lymphocytes	2003
Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. The Journal of clinical investigation, 2003, Volume: 112, Issue:3 Topics: Adenosine; Adenosine Deaminase; Animals; Inflammation; Interleukin-13; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Receptors, Purinergic P1; RNA, Messenger; Signal Transduction	2003
Intracellular localization of differentially regulated RNA-specific adenosine deaminase isoforms in inflammation. The Journal of biological chemistry, 2003, Nov-14, Volume: 278, Issue:46 Topics: Adenosine; Adenosine Deaminase; Alternative Splicing; Animals; Base Sequence; Blotting, Western; Cell Nucleolus; Cell Nucleus; Cloning, Molecular; Cytoplasm; Exons; Green Fluorescent Proteins; HeLa Cells; Humans; Immunohistochemistry; Inflammation; Inosine; Luminescent Proteins; Male; Methionine; Mice; Mice, Inbred C57BL; Microscopy, Electron; Microscopy, Fluorescence; Models, Genetic; Molecular Sequence Data; Protein Isoforms; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA-Binding Proteins; Sequence Homology, Nucleic Acid; Spleen; Transfection; Up-Regulation	2003
Polyserositis induced by psicofuranine in man and comparative toxicity in the rat, mouse, chicken, and monkey. Toxicology and applied pharmacology, 1963, Volume: 5 Topics: Adenosine; Animals; Chickens; Chronic Disease; Haplorhini; Humans; Inflammation; Male; Meat; Mice; Rats; Serositis	1963
Regulation of peripheral inflammation by spinal adenosine: role of somatic afferent fibers. Experimental neurology, 2003, Volume: 184, Issue:1 Topics: Adenosine; Animals; Capsaicin; Feedback; Inflammation; Injections, Spinal; Male; Nerve Fibers; Neurons, Afferent; Neuropeptides; Neutrophil Infiltration; Neutrophils; Oxidopamine; Rats; Rats, Sprague-Dawley; Skin; Spinal Cord; Spinal Nerve Roots; Sympathectomy, Chemical; Sympatholytics	2003
A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2004, Feb-11, Volume: 24, Issue:6 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Caffeine; Disease Models, Animal; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Female; Humans; Inflammation; Inflammation Mediators; Interleukin-1; Macrophages; Matrix Metalloproteinase 12; Metalloendopeptidases; Mice; Mice, Knockout; Microglia; Multiple Sclerosis; Myelin Sheath; Phenotype; Receptor, Adenosine A1; Recurrence; RNA, Messenger; Severity of Illness Index; Spinal Cord; Up-Regulation	2004
Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis. The Journal of biological chemistry, 2004, May-07, Volume: 279, Issue:19 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Bronchi; Cells, Cultured; Chromatography, High Pressure Liquid; Cilia; Cystic Fibrosis; Epithelial Cells; Humans; Inflammation; Lung; Mucous Membrane; Nucleotides; Purinergic P2 Receptor Agonists; Ribonucleases; RNA, Messenger; Time Factors; Up-Regulation	2004
Adenosine receptors control HIV-1 Tat-induced inflammatory responses through protein phosphatase. Virology, 2004, Oct-01, Volume: 327, Issue:2 Topics: Adenosine; Calcium; Cells, Cultured; Gene Products, tat; HIV-1; Humans; Inflammation; Monocytes; Phenethylamines; Phosphoprotein Phosphatases; Receptor, Adenosine A2A; Signal Transduction; tat Gene Products, Human Immunodeficiency Virus; Tumor Necrosis Factor-alpha; U937 Cells	2004
Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circulation research, 2004, Oct-15, Volume: 95, Issue:8 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Blood Coagulation; Carotid Arteries; Cell Adhesion; Chemotaxis, Leukocyte; Coronary Circulation; Coronary Vessels; Cyclic AMP; Endothelium, Vascular; Extracellular Fluid; Female; Gene Targeting; Inflammation; Ischemia; Leukocytes; Male; Mice; Mice, Knockout; Mice, Transgenic; Muscle, Skeletal; Myocardial Ischemia; Platelet Activation; Receptors, Purinergic P1; Reperfusion	2004
Spinal vs. supraspinal antinociceptive activity of the adenosine A(1) receptor agonist cyclopentyl-adenosine in rats with inflammation. European journal of pharmacology, 2004, Sep-24, Volume: 499, Issue:3 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Analgesics; Animals; Blood Pressure; Dose-Response Relationship, Drug; Electric Stimulation; Evoked Potentials, Motor; Female; Hyperalgesia; In Vitro Techniques; Inflammation; Male; Rats; Rats, Wistar; Receptor, Adenosine A1; Reflex, Monosynaptic; Spinal Cord; Spinal Nerve Roots; Stress, Mechanical; Theophylline	2004
Involvement of mast cells in adenosine-mediated bronchoconstriction and inflammation in an allergic mouse model. The Journal of pharmacology and experimental therapeutics, 2005, Volume: 313, Issue:1 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Ambrosia; Animals; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cell Count; Cell Degranulation; Dose-Response Relationship, Drug; Inflammation; Leukocyte Count; Mast Cells; Methacholine Chloride; Mice; Muscarinic Agonists; p-Methoxy-N-methylphenethylamine; Respiratory Hypersensitivity	2005
A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. The Journal of clinical investigation, 2005, Volume: 115, Issue:1 Topics: Adenosine; Adenosine Deaminase; Animals; Chemokines; Cytokines; Inflammation; Lung; Lung Injury; Metaplasia; Mice; Mice, Knockout; Mucus; Receptor, Adenosine A1; RNA, Messenger; Transcription, Genetic	2005
Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo. Blood, 2005, Jun-15, Volume: 105, Issue:12 Topics: Adenosine; Animals; Antigen-Presenting Cells; CD28 Antigens; CD3 Complex; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Flow Cytometry; Inflammation; Interferon-gamma; Interleukin-10; Interleukin-2; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenethylamines; Receptor, Adenosine A2A; Signal Transduction; T-Lymphocytes, Cytotoxic; Th1 Cells; Tumor Necrosis Factor-alpha	2005
Potentiation of neutrophil cyclooxygenase-2 by adenosine: an early anti-inflammatory signal. Journal of cell science, 2005, Apr-01, Volume: 118, Issue:Pt 7 Topics: Adenosine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Models, Animal; Humans; Inflammation; Injections, Subcutaneous; Leukocytes; Lipopolysaccharides; Membrane Proteins; Mice; Mice, Knockout; Mice, Transgenic; Neutrophils; Prostaglandin-Endoperoxide Synthases; Receptor, Adenosine A2A; Signal Transduction; Time Factors	2005
The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends in immunology, 2005, Volume: 26, Issue:6 Topics: Adenosine; Animals; Humans; Immunity; Inflammation; Receptors, Adenosine A2; Time Factors	2005
Expression of human ecto 5' nucleotidase in pig endothelial cells and its implication for adenosine production and xenotransplantation. Nucleosides, nucleotides & nucleic acids, 2005, Volume: 24, Issue:4 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Animals, Genetically Modified; Cell Line; Cells, Cultured; DNA, Complementary; Endothelium, Vascular; Graft Survival; Humans; Inflammation; Swine; Time Factors; Transplantation, Heterologous	2005
Genetically based resistance to the antiinflammatory effects of methotrexate in the air-pouch model of acute inflammation. Arthritis and rheumatism, 2005, Volume: 52, Issue:8 Topics: Acute Disease; Adenosine; Air; Animals; Anti-Inflammatory Agents; Carrageenan; Chromosome Mapping; Disease Models, Animal; Drug Resistance; Exudates and Transudates; Inbreeding; Inflammation; Injections, Subcutaneous; Methotrexate; Mice; Mice, Inbred Strains; Osmolar Concentration; Phenotype; Quantitative Trait Loci	2005
Inflammatory responses in a new mouse model of prolonged hepatic cold ischemia followed by arterialized orthotopic liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2005, Volume: 11, Issue:10 Topics: Adenosine; Allopurinol; Animals; Apoptosis; CD4 Lymphocyte Count; Disease Models, Animal; Glutathione; Immunohistochemistry; Inflammation; Insulin; Ischemia; Liver; Liver Transplantation; Male; Mice; Mice, Inbred BALB C; Organ Preservation Solutions; Postoperative Complications; Raffinose; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocytes; Treatment Outcome	2005
Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:1 Topics: Adenosine; Animals; Chemokines; Female; Gene Expression Regulation; Humans; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Knockout; Neutrophils; Receptor, Adenosine A2A; RNA, Messenger	2006
Role of adenosine in airway inflammation in an allergic mouse model of asthma. International immunopharmacology, 2006, Volume: 6, Issue:1 Topics: Adenosine; Animals; Asthma; beta-N-Acetylhexosaminidases; Bronchoalveolar Lavage Fluid; Chemokine CCL11; Chemokines, CC; Disease Models, Animal; Eosinophil Peroxidase; Immunization; Inflammation; Inflammation Mediators; Male; Mast Cells; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Pollen; Respiratory System	2006
Adenosine A2A receptor activation reduces lung injury in trauma/hemorrhagic shock. Critical care medicine, 2006, Volume: 34, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Inflammation; Lung Diseases; Male; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Reperfusion Injury; Resuscitation; Shock, Hemorrhagic; Shock, Traumatic	2006
Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. Journal of immunology (Baltimore, Md. : 1950), 2006, Apr-01, Volume: 176, Issue:7 Topics: 5'-Nucleotidase; Adenosine; Animals; Bleomycin; Collagen; Fibrosis; Inflammation; Lung Diseases; Mice; Models, Animal; Nucleotidases	2006
Adenosine 2b receptor (A2bR) signals through adenylate cyclase (AC) 6 isoform in the intestinal epithelial cells. Biochimica et biophysica acta, 2006, Volume: 1760, Issue:7 Topics: Adenosine; Adenylyl Cyclases; Animals; Carbachol; CHO Cells; Cholinergic Agonists; Cricetinae; Epithelial Cells; Humans; Inflammation; Intestines; Nitric Oxide; Plasmids; Protein Isoforms; Receptor, Adenosine A2B; Transfection	2006
Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. The Journal of clinical investigation, 2006, Volume: 116, Issue:5 Topics: Adenosine; Animals; Emphysema; Female; Fibrosis; Inflammation; Interleukin-4; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Pulmonary Alveoli; Rats; Species Specificity; Transforming Growth Factor beta; Transforming Growth Factor beta1	2006
A2B adenosine receptors induce IL-19 from bronchial epithelial cells, resulting in TNF-alpha increase. American journal of respiratory cell and molecular biology, 2006, Volume: 35, Issue:5 Topics: Adenosine; Bronchi; Cells, Cultured; Chemokines, CXC; Culture Media, Conditioned; Cyclic AMP; Epithelial Cells; Humans; Inflammation; Interleukins; Monocytes; Protein Isoforms; Receptor, Adenosine A2B; Respiratory Mucosa; Tumor Necrosis Factor-alpha	2006
Adenosine is upregulated during peritonitis and is involved in downregulation of inflammation. Kidney international, 2006, Volume: 70, Issue:4 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Animals; Antihypertensive Agents; Cells, Cultured; Disease Models, Animal; Down-Regulation; Epithelium; Escherichia coli; Female; Humans; Inflammation; Interleukin-6; Leukocytes; Mice; Mice, Inbred Strains; Peritonitis; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptors, Purinergic P1; RNA, Messenger; Theobromine; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthines	2006
New insights into the regulation of inflammation by adenosine. The Journal of clinical investigation, 2006, Volume: 116, Issue:7 Topics: Adenosine; Animals; Inflammation; Mice; Mice, Knockout; Phenotype; Receptor, Adenosine A2B	2006
Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. The Journal of clinical investigation, 2006, Volume: 116, Issue:8 Topics: Adenosine; Animals; Inflammation; Lung; Lung Diseases; Lung Injury; Mice; Mice, Knockout; Purines; Pyrazoles; Receptor, Adenosine A2B; Signal Transduction; Transcription, Genetic	2006
Evaluation of sequential perfusion with Euro-Collins and Belzer solutions for pancreas preservation in rats. Transplantation proceedings, 2006, Volume: 38, Issue:9 Topics: Adenosine; Allopurinol; Animals; Glutathione; Hypertonic Solutions; Inflammation; Insulin; Models, Animal; Organ Preservation; Organ Preservation Solutions; Pancreas; Raffinose; Rats; Rats, Wistar; Time Factors	2006
Methotrexate regulates the expression of glucocorticoid receptor alpha and beta isoforms in normal human peripheral mononuclear cells and human lymphocyte cell lines in vitro. Molecular immunology, 2007, Volume: 44, Issue:8 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Asthma; Autoimmune Diseases; Drug Synergism; Gene Expression Regulation; Humans; Immunosuppressive Agents; Inflammation; Jurkat Cells; Lipopolysaccharides; Lymphocytes; Methotrexate; Protein Isoforms; Receptors, Glucocorticoid; Theobromine; Vasodilator Agents	2007
Protective effects of adenosine A2A agonist during hemorrhagic shock: a simple intervention may result in a complex response. Critical care medicine, 2006, Volume: 34, Issue:12 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Blood Pressure; Erythrocyte Deformability; Humans; Immunologic Factors; Inflammation; Lung Diseases; Phenethylamines; Rats; Reperfusion Injury; Shock, Hemorrhagic; Shock, Traumatic; Time Factors; Toll-Like Receptor 4; Vasodilator Agents	2006
Influence of haemodialysis and left ventricular failure on peripheral A(2A) adenosine receptor expression. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:3 Topics: Adenosine; Adult; Aged; Aged, 80 and over; Biomarkers; Blood Urea Nitrogen; Chromatography; Creatinine; Cross-Sectional Studies; Female; Freeze Drying; Gene Expression; Heart Failure; Humans; Inflammation; Kidney Failure, Chronic; Leukocytes, Mononuclear; Male; Middle Aged; Prognosis; Receptor, Adenosine A2A; Renal Dialysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left	2007
Protective effect of adenosine A2A receptor activation in small-for-size liver transplantation. Transplant international : official journal of the European Society for Organ Transplantation, 2007, Volume: 20, Issue:1 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Apoptosis; Cytokines; Graft Survival; Inflammation; Liver; Liver Transplantation; Male; Models, Animal; Peroxidase; Phenethylamines; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Reperfusion; Transplantation, Isogeneic	2007
Antiinflammatory adaptation to hypoxia through adenosine-mediated cullin-1 deneddylation. The Journal of clinical investigation, 2007, Volume: 117, Issue:3 Topics: Adaptation, Physiological; Adenosine; Animals; Cell Cycle Proteins; COP9 Signalosome Complex; Cullin Proteins; HeLa Cells; Humans; Hypoxia; Inflammation; Intracellular Signaling Peptides and Proteins; Lung; Mice; NF-kappa B; Oligonucleotide Array Sequence Analysis; Peptide Hydrolases; Pneumonia; RNA, Small Interfering	2007
Coronary microvascular reactivity is only partially predicted by atherosclerosis risk factors or coronary artery disease in women evaluated for suspected ischemia: results from the NHLBI Women's Ischemia Syndrome Evaluation (WISE). Clinical cardiology, 2007, Volume: 30, Issue:2 Topics: Adenosine; Atherosclerosis; Biomarkers; Blood Flow Velocity; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Female; Humans; Inflammation; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Risk Factors; Vasodilator Agents	2007
The antiinflammatory mechanism of methotrexate depends on extracellular conversion of adenine nucleotides to adenosine by ecto-5'-nucleotidase: findings in a study of ecto-5'-nucleotidase gene-deficient mice. Arthritis and rheumatism, 2007, Volume: 56, Issue:5 Topics: 5'-Nucleotidase; Adenine Nucleotides; Adenosine; Animals; Antirheumatic Agents; Carrageenan; Gene Expression Regulation, Enzymologic; Inflammation; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Knockout; Tumor Necrosis Factor-alpha	2007
Adenosine deaminase 1 and concentrative nucleoside transporters 2 and 3 regulate adenosine on the apical surface of human airway epithelia: implications for inflammatory lung diseases. Biochemistry, 2007, Sep-11, Volume: 46, Issue:36 Topics: Adenosine; Adenosine Deaminase; Cell Membrane Permeability; Cell Polarity; Cells, Cultured; Cytokines; Epithelial Cells; Humans; Inflammation; Isoenzymes; Kinetics; Lung Diseases; Membrane Transport Proteins; Receptors, Purinergic P1; Respiratory System	2007
Release of ATP in the central nervous system during systemic inflammation: real-time measurement in the hypothalamus of conscious rabbits. The Journal of physiology, 2007, Nov-15, Volume: 585, Issue:Pt 1 Topics: Adenosine; Adenosine Triphosphate; Animals; Central Nervous System; Consciousness; Fever; Hypothalamus; Inflammation; Lipopolysaccharides; Male; Neuroglia; Neurons; Purinergic P2 Receptor Antagonists; Rabbits	2007
Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 324, Issue:2 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Cytokines; Inflammation; Macrophages, Peritoneal; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Adenosine A2B	2008
Adenosine-mediated alteration of vascular reactivity and inflammation in a murine model of asthma. American journal of physiology. Heart and circulatory physiology, 2008, Volume: 294, Issue:5 Topics: Acetylcholine; Adenosine; Administration, Inhalation; Allergens; Ambrosia; Animals; Aorta; Asthma; Disease Models, Animal; Dose-Response Relationship, Drug; Flavins; Inflammation; Inflammation Mediators; Lung; Male; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Plant Proteins; Receptor, Adenosine A1; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Vasodilation; Vasodilator Agents; Xanthines	2008
CD73-generated adenosine restricts lymphocyte migration into draining lymph nodes. Journal of immunology (Baltimore, Md. : 1950), 2008, May-01, Volume: 180, Issue:9 Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Agonists; Adenosine Monophosphate; Aminopyridines; Animals; Cell Movement; Dendritic Cells; Endothelium, Vascular; Inflammation; L-Selectin; Lipopolysaccharides; Lymph Nodes; Mice; Mice, Knockout; Receptor, Adenosine A2B; T-Lymphocytes; Tumor Necrosis Factor-alpha; Up-Regulation; Venules	2008
A mathematical model of glutathione metabolism. Theoretical biology & medical modelling, 2008, Apr-28, Volume: 5 Topics: Adenosine; Antioxidants; Autistic Disorder; Carbon; Cytosol; Down Syndrome; Glutathione; Humans; Inflammation; Kinetics; Liver; Models, Biological; Models, Theoretical; Oxidative Stress	2008
Anti-inflammatory preconditioning by agonists of adenosine A1 receptor. PloS one, 2008, May-07, Volume: 3, Issue:5 Topics: Adenosine; Adenosine A1 Receptor Agonists; Animals; Anti-Inflammatory Agents; Epithelium; Female; Inflammation; Ischemic Preconditioning; Mice; Mice, Knockout; Peritonitis; Pertussis Toxin; Receptor, Adenosine A2A	2008
Cyclic nucleotides in immune responses and allergy. Advances in cyclic nucleotide research, 1980, Volume: 12 Topics: Adenosine; Animals; Antigens; Basophils; Cyclic AMP; Histamine Release; Humans; Hypersensitivity, Immediate; Immunity, Cellular; Indomethacin; Inflammation; Isoproterenol; Kinetics; Neutrophils; Prostaglandins E; T-Lymphocytes	1980
Adenosine receptors on human inflammatory cells. Advances in experimental medicine and biology, 1984, Volume: 165 Pt A Topics: Adenosine; Alprostadil; Cyclic AMP; Humans; Inflammation; Kinetics; Lymphocytes; Prostaglandins E; Receptors, Cell Surface; Receptors, Purinergic; Theophylline	1984
Characteristics of prostaglandin E1 potentiation of inflammatory activity of some agents. Prostaglandins, 1980, Volume: 19, Issue:1 Topics: Adenosine; Animals; Bradykinin; Carrageenan; Drug Synergism; Edema; Histamine; Indomethacin; Inflammation; Male; Mesenteric Arteries; Mesenteric Veins; Norepinephrine; Papaverine; Prostaglandins E; Rats; Serotonin; Skin; Time Factors; Vasodilation	1980
The antiinflammatory effects of methotrexate are mediated by adenosine. Advances in experimental medicine and biology, 1994, Volume: 370 Topics: Acyltransferases; Adenosine; Adenosine Deaminase; Aminoimidazole Carboxamide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Hydroxymethyl and Formyl Transferases; Inflammation; Kinetics; Leukocytes; Methotrexate; Mice; Phosphoribosylaminoimidazolecarboxamide Formyltransferase; Purinergic P1 Receptor Antagonists; Ribonucleotides; Theobromine; Xanthines	1994
The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation. The Journal of clinical investigation, 1993, Volume: 92, Issue:6 Topics: Adenosine; Adenosine Deaminase; Aminoimidazole Carboxamide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Disease Models, Animal; Female; Inflammation; Kinetics; Leukocytes; Methotrexate; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Ribonucleotides; Spleen; Theobromine; Time Factors	1993
Adenosine enhances IL-10 secretion by human monocytes. Journal of immunology (Baltimore, Md. : 1950), 1996, Jun-01, Volume: 156, Issue:11 Topics: Adenosine; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Inflammation; Interleukin-10; Lipopolysaccharides; Monocytes; Receptors, Purinergic P1; Tumor Necrosis Factor-alpha	1996
Effect of buflomedil on the neutrophil-endothelial cell interaction under inflammatory and hypoxia conditions. Haemostasis, 1996, Volume: 26 Suppl 4 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Cell Adhesion; Cell Hypoxia; Cells, Cultured; Cytokines; Endothelium, Vascular; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1; Neutrophils; P-Selectin; Pyrrolidines; Theophylline; Umbilical Veins	1996
Spinal cord adenosine receptor stimulation in rats inhibits peripheral neutrophil accumulation. The role of N-methyl-D-aspartate receptors. The Journal of clinical investigation, 1996, Dec-15, Volume: 98, Issue:12 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Anti-Inflammatory Agents; Carrageenan; Catheterization; Central Nervous System; Dexamethasone; Excitatory Amino Acid Antagonists; Inflammation; N-Methylaspartate; Neutrophils; Peroxidase; Phenethylamines; Propionates; Purinergic P1 Receptor Antagonists; Rats; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Receptors, Purinergic P1; Signal Transduction; Skin; Spinal Cord; Theobromine	1996
Naturally occurring 2'-O-methylpurine nucleosides with hypotensive properties. Cellular and molecular life sciences : CMLS, 1998, Volume: 54, Issue:2 Topics: Adenosine; Adenosine Deaminase; Animals; Antihypertensive Agents; Blood Pressure; Inflammation; Inosine; Methyldopa; Molecular Structure; Purine Nucleosides; Rabbits; Rats; Rats, Inbred SHR; Skin	1998
Dexamethasone attenuates acute macromolecular efflux increase evoked by smokeless tobacco extract. Journal of applied physiology (Bethesda, Md. : 1985), 1999, Volume: 87, Issue:2 Topics: Adenosine; Animals; Arterioles; Bradykinin; Cheek; Cricetinae; Dexamethasone; Dextrans; Fluorescein-5-isothiocyanate; Inflammation; Macromolecular Substances; Male; Mesocricetus; Microcirculation; Microscopy, Video; Mouth Mucosa; Plant Extracts; Plants, Toxic; Tobacco, Smokeless; Vasodilator Agents	1999
Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells. The Journal of biological chemistry, 2000, Feb-11, Volume: 275, Issue:6 Topics: Adenosine; Animals; beta-N-Acetylhexosaminidases; Blood Pressure; Gene Targeting; Heart Rate; Inflammation; Lipopolysaccharides; Mast Cells; Mice; Mice, Knockout; Protein Binding; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Tumor Necrosis Factor-alpha; Xanthines	2000
Chronic hypersensitivity for inflammatory nociceptor sensitization mediated by the epsilon isozyme of protein kinase C. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Jun-15, Volume: 20, Issue:12 Topics: Adenosine; Animals; Carrageenan; Dinoprostone; Enzyme Inhibitors; Hindlimb; Hyperalgesia; Inflammation; Isoenzymes; Male; Nociceptors; Pain; Phenethylamines; Protein Kinase C; Protein Kinase C-epsilon; Protein Kinase Inhibitors; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors	2000
Accelerated resequestration of cytosolic calcium and suppression of the pro-inflammatory activities of human neutrophils by CGS 21680 in vitro. British journal of pharmacology, 2000, Volume: 130, Issue:4 Topics: Adenosine; Calcium; Calcium Radioisotopes; Cyclic AMP; Cytosol; Dose-Response Relationship, Drug; Fura-2; Humans; Inflammation; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Pancreatic Elastase; Phenethylamines; Purinergic P1 Receptor Agonists; Purinergic P2 Receptor Antagonists; Superoxides; Thapsigargin; Triazines; Triazoles	2000
Endogenous adenosine and secondary injury after chest trauma. The Journal of trauma, 2000, Volume: 49, Issue:5 Topics: Acidosis; Adenosine; Aminoimidazole Carboxamide; Animals; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Drug Evaluation, Preclinical; Hemodynamics; Hypercapnia; Inflammation; Leukocyte Count; Peroxidase; Ribonucleosides; Survival Analysis; Swine; Thoracic Injuries; Wounds, Nonpenetrating	2000
Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage. Annals of neurology, 2001, Volume: 49, Issue:6 Topics: Adenosine; Adenylyl Cyclases; Animals; Apoptosis; Cerebral Hemorrhage; Chemotaxis, Leukocyte; Humans; In Situ Nick-End Labeling; Inflammation; Injections, Intraventricular; Male; Neutrophils; Phenethylamines; Phytohemagglutinins; Purinergic P1 Receptor Agonists; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptor, Adenosine A3; Receptors, Purinergic P1; RNA, Messenger; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha; U937 Cells	2001
Protection from reperfusion injury after cardiac transplantation by inhibition of adenosine metabolism and nucleotide precursor supply. Circulation, 2001, Sep-18, Volume: 104, Issue:12 Suppl 1 Topics: Adenine; Adenosine; Adenosine Deaminase; Adenosine Deaminase Inhibitors; Adenosine Kinase; Animals; Cardioplegic Solutions; Creatinine; Deoxyadenosines; Enzyme Inhibitors; Heart Transplantation; In Vitro Techniques; Inflammation; Male; Myocardial Reperfusion Injury; Myocardium; Neutrophil Infiltration; Perfusion; Rats; Rats, Sprague-Dawley; Ribose; Treatment Outcome	2001
Effects of adenosine on ischaemia-reperfusion injury associated with rat pancreas transplantation. The British journal of surgery, 2001, Volume: 88, Issue:10 Topics: Adenosine; Animals; Graft Survival; Inflammation; Lipase; Male; Neutrophils; Nitric Oxide; Nucleotides; Pancreas Transplantation; Rats; Rats, Sprague-Dawley; Reperfusion Injury	2001
Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. European journal of pharmacology, 2002, Mar-08, Volume: 438, Issue:3 Topics: Adenosine; Allergens; Animals; Anti-Inflammatory Agents; Asthma; Blood Pressure; Budesonide; Dose-Response Relationship, Drug; Inflammation; Lung; Male; Ovalbumin; Phenethylamines; Purinergic P1 Receptor Agonists; Rats; Rats, Inbred BN; Receptor, Adenosine A2A; Triazines; Triazoles; Vascular Resistance	2002
Effect of adenosine on ischaemia-reperfusion injury associated with rat pancreas transplantation. The British journal of surgery, 2002, Volume: 89, Issue:4 Topics: Adenosine; Animals; Drug Stability; Inflammation; Pancreas Transplantation; Preservatives, Pharmaceutical; Rats; Reperfusion Injury	2002
Airway hyperresponsiveness to adenosine induced by lipopolysaccharide in Brown Norway rats. British journal of pharmacology, 2002, Volume: 136, Issue:1 Topics: Adenosine; Animals; Anti-Asthmatic Agents; Biomarkers; Blood Pressure; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cromolyn Sodium; Dose-Response Relationship, Drug; Drug Synergism; Heart Rate; Inflammation; Lipopolysaccharides; Male; Mast Cells; Methacholine Chloride; Methysergide; Purinergic P1 Receptor Antagonists; Rats; Serotonin; Vasoconstrictor Agents	2002
Role of prostaglandin-mediated vasodilatation in inflammation. Nature, 1977, Dec-08, Volume: 270, Issue:5637 Topics: Adenosine; Bradykinin; Cell Membrane Permeability; Drug Synergism; Exudates and Transudates; Histamine; Inflammation; Prostaglandins; Regional Blood Flow; Vasodilation	1977
Adenosine. The signal of life? Circulation, 1991, Volume: 84, Issue:2 Topics: Adenosine; Animals; Coronary Disease; Embolism; Free Radicals; Humans; Inflammation; Microcirculation; Myocardial Reperfusion Injury; Oxygen	1991
Immune-related intestinal chloride secretion. II. Effect of adenosine on T84 cell line. The American journal of physiology, 1990, Volume: 258, Issue:5 Pt 1 Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Calcium; Cell Line; Chlorides; Cyclic AMP; Cyclic GMP; Cytosol; Electrolytes; Epithelium; Histamine; Humans; Inflammation; Kinetics; Phenylisopropyladenosine; Phosphorylation; Protein Kinases; Theophylline	1990
Effect of adenosine in some models of inflammation and anaphylaxis in experimental animals. Archivum immunologiae et therapiae experimentalis, 1989, Volume: 37, Issue:5-6 Topics: Adenosine; Anaphylaxis; Animals; Disease Models, Animal; Female; Guinea Pigs; Inflammation; Male; Mice; Mice, Inbred C57BL; Ozone; Pulmonary Edema; Rats; Rats, Inbred Strains	1989
The erythrocyte as instigator of inflammation. Generation of amidated C3 by erythrocyte adenosine deaminase. The Journal of clinical investigation, 1989, Volume: 84, Issue:2 Topics: Adenosine; Adenosine Deaminase; Adult; Ammonia; Coformycin; Complement C3; Erythrocytes; Female; Humans; Inflammation; Male; Nucleoside Deaminases; Pentostatin	1989